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Abstract 
 Sleep problems are one of the most commonly reported concerns among parents of children 
with Autism Spectrum Disorder (ASD). Unless treated effectively, sleep problems are highly 
persistent and sometimes continue into adulthood. Given the prevalence of sleep problems and 
long-term effects associated with sleep problems (i.e., impaired daytime and adaptive functioning, 
social interaction and communication difficulties), it is crucial that effective treatments are 
identified. Behavioural treatments such as scheduled awakenings and extinction meet the criteria to 
be considered possibly efficacious intervention and more future replications are needed in order to 
be considered well-established interventions. Similarly, in the extant literature, there is an emerging 
body of evidence demonstrating the effectiveness of behaviourally-based, parent-implemented sleep 
treatments that are informed by functional behavioural assessment (FBA). However, further 
replication and expansion of this research is also required. As a starting point, factors that may 
affect response to behaviourally-based, parent-implemented sleep treatments need to be investigated 
and identified.  
The purpose of this study was, therefore, to investigate and identify the complex array of 
factors that may affect responses to FBA-informed and parent-implemented behavioural sleep 
interventions. Following Kazdin and Whitley (2006), various factors associated with the scope and 
severity of the child’s problem were used to define the dimensions of clinical complexity. These 
factors included impaired daytime functioning and behaviour, sleep problems, presence of 
comorbid psychopathology and medications use. Impaired daytime functioning and behaviour were 
measured using the Child Behaviour Checklist (CBCL), the Gilliam Autism Rating Scale, Second 
Edition (GARS-2), and the Vineland Adaptive Behaviour Scale, Second Edition (VABS II). 
Children’s sleep problems were measured using the Children’s Sleep Habits Questionnaire (CSHQ). 
Presence of comorbid psychopathology was measured using a categorical variable of comorbidity 
and medications use was measured using a categorical variable of medications. A Sleep Problem 
Severity (SPS) score was calculated for each child in order to objectively measure the changes 
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before and after treatment. A pretest-posttest research design was used to analyse existing clinical 
data obtained from 31 children who had parent reported sleep disturbance, and who had received an 
FBA-informed intervention. Results from paired sample t test showed that there was a statistically 
significant reduction in sleep problem severity between pre- and post-treatment. Based on 
evaluation of modified Brinley plots, 27 out of the of 31 children showed improvement post-
treatment.  Factor analysis identified three latent variables underlying behaviour problems, sleep 
problems, autism severity, communications, medications and comorbidity. The latent variable 
Behaviour and Sleep Problems was identified as a statistically significant predictor of changes in 
SPS score post-treatment. The second latent variable Medication-Communication was not a 
statistically significant predictor of changes in SPS score post-treatment. The third latent variable 
Psychopathology Severity was also not a statistically significant predictor of changes in SPS score 
post-treatment. The present findings add to the limited literature investigating the child 
characteristics that may impact upon response to behavioural sleep interventions in children with 
ASD. In terms of treatment, additional components to address behavioural problems will need to be 
formulated and included as part of the sleep intervention treatment package so that both behaviour 
and sleep problems can be addressed together to enhance treatment responses. Further research is 
still needed to develop a deeper understanding of the complex array of factors that may affect 
treatment responses.  
  
  





Research suggests that up to 80% of children and adolescents (referred to as children 
throughout the rest of this thesis) with Autism Spectrum Disorder (ASD) experience some form of 
sleep problem (Kose, Yilmaz, Ocakoglu, & Ozbaran, 2017; Krakowiak, Goodlin-Jones, Hertz-
Picciotto, Croen, & Hansen, 2008; Mannion, Leader, & Healy, 2013; Singh & Zimmerman, 2015; 
Turner & Johnson, 2012). This is compared to only 25% to 50% of typically developing children 
(Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014). The most commonly reported sleep 
problems in children with developmental disorders, of which ASD is a sub-set, are classified as 
behavioural insomnias (Souders et al., 2009). This includes sleep onset delay, refusal to sleep alone, 
short sleep duration, settling difficulties, frequent night wakings, early morning wakings, 
irregular/problematic bedtime routines, and excessive daytime sleepiness (Richdale & Schreck, 
2009). Without intervention, children with ASD are unlikely to outgrow their sleep problems 
(Hodge et al., 2014), and in many cases, they might in fact worsen over time (Sivertsen, Posserud, 
Gillberg, Lundervold, & Hysing, 2012).  
Sleep problems in children with ASD have been associated with increased severity of autism 
symptomatology, including greater communication and social skills difficulties, and restricted and 
repetitive behaviours (Cortesi, Giannotti, Ivanenko, & Johnson, 2010; Goldman et al., 2009; 
Hollway & Aman, 2011; Malow, McGrew, Harvey, Henderson, & Stone, 2006; Richdale & 
Schreck, 2009; Schreck, Mulick, & Smith, 2004), increased rates of internalising and externalising 
behaviour problems and poorer adaptive skill development (Sikora, Johnson, Clemons, & Katz, 
2012). Given the prevalence of sleep problems in children with ASD, and the significant association 
found between sleep problems and daytime functioning, early identification and treatment is 
essential. 
Page 13 of 167  
To date, systematic reviews have identified that both melatonin (Guenole & Baleyte, 2011; 
Hollway & Aman, 2011; Rossignol & Frye, 2011; Sung, Fung, Cai, & Ooi, 2010) and behavioural 
interventions (Mindell, Kuhn, Lewin, Meltzer, & Sadeh, 2006; Turner & Johnson, 2012; Vriend, 
Corkum, Moon, & Smith, 2011) are effective in addressing sleep problems in children with ASD. 
However, we know very little about child variables (e.g., behaviour problems, sleep problems, 
medications, comorbid psychopathology) that may effect treatment outcome. The aim of the current 
study is to enhance our understanding of the relationship between child complexity variables and 
response to functional behavioural assessment (FBA) based intervention among children with ASD 
and sleep problems.   
This chapter provides an overview of autism and associated challenging behaviours, 
common behavioural insomnias in children with autism, types and causes of sleep problems in 
children with autism, common treatments for sleep problems, and case complexity and treatment 
responses.  
Autism Spectrum Disorder 
Definition. Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder 
characterised by impairments in social communication and interaction and restricted, repetitive 
patterns of behaviour (American Psychiatric Association [APA], 2016). Impairments in 
communication could include difficulties with language comprehension and expression (e.g., 
idiosyncratic language use, echolalia) and difficulties with nonverbal communication such as hand 
gestures or body language, and limited facial expressions. Impairments in social interaction could 
include difficulties in interacting with others, establishing and maintaining friendships, making eye 
contact, and recognising facial expressions. Restricted and repetitive behavioural patterns may 
include vocal stereotypy and repetitive body movements (e.g., body rocking or hand flapping) 
(APA, 2016). Autism is a largely heterogeneous disorder and the extent of impairment varies 
greatly across individuals (Waterhouse et al., 1996). The heterogeneity in clinical presentation is 
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heavily influenced by several factors such as genetic variability, comorbidity, and gender (Masi, 
DeMayo, Glozier, & Guastella, 2017).  
Prevalence. Autism Spectrum Disorder is about three to four times more common among 
boys than girls (Baio et al., 2014; Lord, Elsabbagh, Baird, & Veenstra-Vanderweele, 2018). In the 
United States of America, it is estimated that 1 in 43 children have a diagnosis of ASD (Xu, 
Strathearn, Liu, & Bao, 2018). This compares to a prevalence of 1 in 63 children (Baron-Cohen et 
al., 2009) in the United Kingdom, and 1 in 675 children in Asia (Sun & Allison, 2010). Globally, in 
2010, the population prevalence was estimated to be 1 in 132 persons (Baxter et al., 2015). 
Prevalence data is unavailable in New Zealand; however, it is estimated that approximately 1 in 100 
people in this country have a diagnosis of ASD (Ministries of Health and Education, 2016).  
Etiology. The etiology of ASD is largely unknown; however, it is thought to be the result of 
a combination of genetic, biological, and environmental factors.   
Genetic factors. Neurobiological and genetic factors have been identified in the past decade 
(Lyall et al., 2017) with estimates suggesting that the heritability of autism ranges from 50-90% 
(Fakhoury, 2015; Sandin et al., 2014). Two recent twin studies examined concordance rates 
between monozygotic and dizygotic twin pairs and found that concordance for autism in 
monozygotic twin pairs was typically at least triple that in dizygotic twin pairs indicated that autism 
was predominantly caused by genetic factors (Colvert et al., 2015; Nordenbaek, Jorgensen, Ohm 
Kyvik, & Bilenberg, 2014). Colvert et al. (2015) examined the genetic and environmental 
contributions to autism in a population-based sample of twins born in England and Wales from 
1994 to 1996. The study found concordance rates for ASD was 87% in monozygotic twins and 22% 
in dizygotic twin and concluded that liability to autism derived from substantial genetic and 
moderate nonshared environmental influences (Colvert et al., 2015). Nordenbaek et al. (2014), used 
data from the nationwide Danish Twin Registry, to conduct a genetic epidemiological study of 
autism based on 7,296 same sexed twin pairs aged 3 to 14 years.  A clinical assessment, diagnostic 
interview, observation and cognitive examination was performed on 13 monozygotic twin and 23 
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dizygotic twin pairs. The concordance rate for ASD was found to be 95.2% in monozygotic twins 
and 4.3% in dizygotic twin.  The high monozygotic and low dizygotic concordance rate suggested 
the heritability of autism (Nordenbaek, Jorgensen, Kyvik, & Bilenberg, 2014). Studies of twins can 
differentiate genetic versus environmental effects and have thus been a powerful tool in providing 
evidence of the importance role of genetic factors in ASD (Nordenbaek et al., 2014).  
Although autism is highly heritable (Tick, Bolton, Happe, Rutter, & Rijsdijk, 2016), no 
single pattern of inheritance (either autosomal dominant or recessive) is observable within families 
(Howes, Rogdaki, Findon, Wichers, & Charman, 2018). In the majority of cases of autism, the 
genetic risk is polygenic, involving multiple single nucleotide polymorphisms (SNPs), each of 
minor effect (Clarke et al., 2015; Gaugler et al., 2014). Single nucleotide polymorphisms are the 
most common type of genetic variation among individuals (U.S. National Library of Medicine 
[NLM], 2018). They can act as biological markers and also be used to track the inheritance of 
disease carrying genes within families (NLM, 2018). Based on existing literature, Gaugler et al. 
(2014) showed that SNP-based heritability, called common inherited variations, accounted for 49% 
of autism liability; rare inherited variations accounted for 3%; and de novo variations, which arise 
spontaneously before or shortly after fertilisation (Daly, 2017), accounted for 3% of autism liability. 
A combination of both common and unique environmental factors accounted for the remaining 41% 
of autism liability (Gaugler et al., 2014).  
Environmental factors. A number of environmental factors – preconception, prenatal, 
perinatal, and postnatal – have been hypothesised to influence the emergence and development of 
ASD (Mandy & Lai, 2016). Environmnental factors can be considered any factors that are not 
genetic or inherited (Mandy & Lai, 2016). Many of these risk factors are outlined below.  
Preconception environmental risks. Preconception environmental risk factors that have been 
identified include advanced parental age at the time of a child’s birth (Gardener, Spiegelman, & 
Buka, 2009; Wu et al., 2017), and a short interpregnancy (i.e., interpregnancy interval of less than 
12 months) or long interpregnancy interval (i.e. interpregnancy interval of more than 60 months) 
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(Cheslack-Postava et al., 2014). Each of these risk factors have been identified in a number of 
studies of children with ASD (Hultman, Sandin, Levine, Lichtenstein, & Reichenberg, 2011; Sandin 
et al., 2012; Cheslack-Postava et al., 2014; Durkin, DuBois, & Maenner, 2015).   
Prenatal and perinatal factors. Prenatal risk factors associated with increased risk of ASD 
include air pollution, in utero valproate exposure, maternal gestational bleeding, maternal infections 
and fever during pregnancy, maternal diabetes and maternal prenatal psychiatric medication or 
psychoactive drugs use (Atladottir et al., 2010; Becerra, Wilhelm, Olsen, Cockburn, & Ritz, 2013; 
Christensen et al., 2013; Gardener et al., 2009; Jiang et al., 2016; Jung, Lin, & Hwang, 2013; 
Kalkbrenner et al., 2018; Lam et al., 2016; Lee et al., 2015; Talbott, Marshall, Rager, Arena, 
Sharma, & Stacy, 2015; Volk, Hertz-Picciotto, Delwiche, Lurmann, & McConnell, 2011; Xiang et 
al., 2015; Zerbo et al., 2013; 2015). Perinatal and neonatal factors found to be associated with ASD 
include birth complications such as abnormal foetal presentation, umbilical-cord complications, 
foetal distress, birth injury or trauma, low birth weight, congenital malformation, respiratory 
distress or no breathing after birth, and medical intervention in the first month (Gardener, 
Spiegelman, & Buka, 2011). The authors suggested that the observed association between perinatal 
and neonatal factors and risk of autism might be influenced by and/or operate in combination with 
pre-existing prenatal factors (Gardener et al., 2011). 
Gene-Environment interplay - interaction and correlation. Genetic and environmental 
factors are not simply additive (Mandy & Lai, 2016) and are best conceptualised as two broad 
forms of gene-environment interplay – interaction and correlation (Rutter, 2006; Rutter et al., 
1997). Gene-environment interaction refers to the fact that genetic factors can be modified in the 
presence of specific environmental factors or the effects of the environment are influenced by the 
existence of a specific genetic predisposition (Rutter, 2006). Gene-environment correlation refers to 
the indirect effects of genetic operating through specific environment (Mandy & Lai, 2016). Hence, 
phenotypic variances of behavioural or clinical characteristics of ASD can be analysed by looking 
at the contribution of genetic and environmental factors, and the gene-environment interplay 
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(Chaste & Leboyer, 2012; Kim & Leventhal, 2015; Mandy & Lai, 2016; Meek, Lemery-Chalfant, 
Jahromi, & Valiente, 2013). Based on the findings from an empirical study that siblings unaffected 
by ASD had fewer prenatal and perinatal complications than their affected siblings, some level of 
interactions existed between genetic background and environmental factors such that siblings with 
ASD might react differently to the same environmental stimuli and might have less tolerance to the 
prenatal experience compared with their siblings (Glasson et al., 2004, as cited in Chaste & 
Leboyer, 2012).  Using a developmental psychopathology framework to synthesise literature 
focusing on gene-environment interaction and correlation, Mandy and Lai (2016) suggested gene-
environment interplay as a possible interpretation for findings such as advanced paternal and 
maternal ages might independently increase offspring risk for ASD, in utero valproate exposure 
might serve as a causal risk factor for ASD, prenatal folate intake seemed to operate as a gene-
environment interplay by providing the strongest protective effect for mothers and children who 
have a genotype associated with inefficient folate metabolism.    
Challenging Behaviour in Children With ASD 
Challenging behaviours are commonly defined as those behaviours that are physically 
dangerous, not socially acceptable, and that have a negative impact on education or living 
placement (Matson, Mahan, Hess, Fodstad, & Neal, 2010). It is estimated that approximately 6.0% 
to 9.3% of typically developing preschool aged children exhibit some form of challenging 
behaviour (Briggs-Gowan, Carter, Skuban, & Horwitz, 2001). By comparison, 95% percent of 
children aged 2 to 18 with ASD exhibit at least one form of challenging behaviour (Matson, 
Wilkins, & Macken, 2009; Jang, Dixon, Tarbox, & Granpeesheh, 2011). In children with autism, 
challenging behaviours that are commonly observed include unusual eating habits, sleep problems, 
tantrums, aggression, stereotypy, property destruction, and self-harm (Dominick, Davis, Lainhart, 
Tager-Flusberg, & Folstein, 2007; Jang et al., 2011; Matson et al., 2009). Challenging behaviors in 
children with ASD are highly persistent if untreated, and are commonly reported not only in 
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childhood, but also adolescence and adulthood (Bauminger, Solomon, & Rogers, 2010; Conroy, 
Dunlap, Clarke, & Alter, 2005).   
Externalising behaviours. Externalising behaviours are negative behaviours toward others 
and include tantrums, defiance, noncompliance, and aggressive behaviours (Sellinger & Elder, 
2016; Farmer et al., 2015). Two studies that each included over 1000 children with ASD between 
the ages of 2 and 17 found that approximately 54% respondents were currently engaging in some 
form of aggressive behaviour (Kanne & Mazurek, 2011: Mazurek, Kanne, & Wodka, 2013). In a 
further study, including 414 children with ASD aged 1 to 21 years old, Farmer et al. (2016) found 
that 50% of those with ASD engaged in at least one form of challenging behaviour as measure on 
the Children’s Scale for Hostility and Aggression: Reactive/Proactive (C-SHARP). This rate is far 
in excess of what is observed among children with typical development (Briggs-Gowan, Carter, 
Skuban, & Horwitz, 2001).  
Several researchers have suggested that there is an association between externalising 
behaviours problems and core ASD symptoms whereby, core autism symptoms such as difficulties 
related to social function (i.e. interpreting social cues and understanding expectations) contribute to 
rates of externalising behaviours (Shea, Payne, & Russo, 2018; Volker et al., 2010). Konst et al. 
(2013) suggest that as the severity of core symptoms increases, communication, social skills, and 
comprehension abilities might be affected leading to an increased likelihood of externalising 
behaviour problems. Other co-occurring problems commonly observed in children with ASD, such 
as sleep and sensory problems, are also thought to exacerbate the likelihood of externalising 
behaviour problems (Mazurek et al., 2013).    
Internalising behaviours. Internalising behaviour refers to behaviour that is internal and 
not observable and reflects emotional or psychological state (Liu, Chen, & Lewis, 2011). 
Depression and anxiety disorders are two of the most frequent comorbid conditions in autism 
population (Ghaziuddin, Ghaziuddin, & Greden, 2002; White, Oswald, Ollendick, & Scahill, 2009). 
White et al. (2009) conducted a literature review exploring the association between autism and 
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anxiety and found that between 11% and 84% of children with autism showed signs of clinically 
significant anxiety. In comparison, anxiety disorders in typically developing children were 
estimated to be between 2.2% and 27% (Costello, Egger, & Angold, 2005). Some researchers 
suggested that anxiety might be inherent in autism due to the presence of social avoidance, deficits 
in social awareness and experience, or heightened sensitivity to environmental stimuli and sensory 
modulation dysfunction (Chalfant, Rapee, & Carroll, 2007; Storch et al., 2013; White et al., 2009).  
Recent research suggests that 13% to 44% of children with ASD meet diagnostic criteria for 
depression (Leyfer et al., 2006; Salazar et al., 2015; Strang et al., 2012). There are a number of 
plausible explanations for why children with ASD experience increased rates of depression, 
including the fact that social deficits inherent in children with ASD might aggravate depression 
symptoms in socially challenging environments (Gadow, Guttmann-Steinmetz, Rieffe, & 
DeVincent, 2012). In addition, due to the social and communication deficits, children with autism 
might avoid group interactions, experience difficulty in expressing themselves and seeking support, 
which may lead to symptoms of depression (Andersen, Skogli, Hovik, Egeland, & Oie, 2015).  
Sleep and Children With ASD 
 The function of sleep. Sleep is a critical component of healthy development and is required 
for children’s physical and mental health (Chaput et al., 2016; Hong, Kahn, & Perez, 2017). The 
negative impact of poor sleep on behaviour and cognition in typically developing children is well 
recognised (Chawla, Burgess, & Heussler, 2018). There is, however, a lack of consensus 
concerning the function of sleep (Krueger, Frank, Wisor, & Roy, 2016). There is substantial 
evidence to suggest that sleep has an important role in preserving calories, immune enhancement, 
restoring brain energy, neuronal and neuroglial connectivity, and performance restoration (Krueger 
et al., 2016).  
One way to determine the function of sleep is to conduct sleep-restriction experiments 
(Wiggs, 2007). A number of studies have conducted sleep restriction experiments with children and 
have found that this has a negative effect such as an increase in parent-reported oppositional and 
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inattentive behaviour, a decrease in positive mood, behavioural/emotional problems at older age, 
inability to take full advantages of positive experiences, less adaptive in challenging contexts, and 
an inability to manage emotion regulation effectively (Berger, Miller, Seifer, Cares, & Lebourgeois, 
2012; Fallone, Owens, & Deane, 2002; Gregory & O’Connor, 2002). Given the potential impact of 
sleep deprivation on optimal cognitive and emotional functioning, it is important that sleep 
problems are addressed properly.  
Sleep problems and children with ASD. One of the most commonly reported challenging 
behaviours experienced by children with ASD is sleep problems (Dominick et al., 2007; Levin & 
Scher, 2016; Wiggs & Stores, 2004; Williams, Sears, & Allard, 2004). Prevalence rates of sleep 
problems in children with ASD range from 44% to 89%. (Cotton & Richdale, 2006; Hodge et al., 
2014; Krakowiak et al., 2008; Liu, Hubbard, Fabes, & Adam, 2006; Wiggs & Stores, 2004). This 
compares to 11% to 50% of typically developing children (Cotton & Richdale, 2006; 2010; Hodge 
et al., 2014; Krakowiak et al., 2008). Several possible reasons for such a wide variation in terms of 
prevalence rates are variations in the definition of sleep problems, different instruments used to 
measure sleep problems, and age-related changes in sleep problems (Hodge et al., 2014; Krakowiak 
et al., 2008). Compared to typically developing children, sleep problems in children with ASD were 
more likely to persist or increased marginally as the children with ASD grew older (Hodge et al., 
2014).      
Trajectory of sleep problems in children with ASD. Unless treated effectively, sleep 
problems often last for many years, sometimes continuing into adulthood (Baker & Richdale, 2015; 
Cohen, Conduit, Lockley, Rajaratnam, & Cornish, 2014; Cortesi et al., 2010; Davis et al., 2012; 
Ming, Brimacombe, Chaaban, Zimmerman-Bier, & Wagner, 2008; Robinson & Richdale, 2004; 
Tani et al., 2004). Wiggs and Stores (2004) reported that 63% of children with an autism diagnosis 
and sleep problems experienced persistence of sleep problems over time. In a study to identify age-
related changes in multiple domains of the sleep of children with autism versus changes in typically 
developing children, Hodge et al. (2014) reported significantly poorer sleep quality and quantity in 
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children with autism, particularly around the age of 6 to 9 years old. The rates of sleep difficulties 
were higher for the older children with autism than the younger children, 87.5% versus 84%, 
respectively. In contrast, within typically developing children, the rates of sleep difficulties were 
lower for the older children than the younger children, 37.5% versus 72%. Similarly, in a 
longitudinal study by Verhoeff et al., (2018), it was found that sleep problems tended to decrease 
over time for typically developing individuals yet increase among those with traits of ASD. Given 
that sleep problems in children with autism are consistently associated with impaired daytime 
functioning and well-being, it is crucial that effective interventions are provided at a young age 
(Cuomo et al., 2017).    
Types of sleep problems in children with ASD. It is impossible to describe all sleep 
disorders occurring in children with autism within the scope of this thesis. Hence, the discussion is 
confined to those sleep disorders most commonly reported among this group of children. The most 
inclusive categories that had been used to define childhood sleep disorders were dyssomnias and 
parasomnias (Schreck & Mulick, 2000) 
Dyssomnias. A greater frequency of dyssomnias was found in children with ASD, as 
compared with children with intellectual disability, children with specific developmental problems 
and typically developing children (Schreck, 1997, as cited in Richdale, 1999). In general, 
dyssomnias refers to difficulty falling asleep, frequent night wakings, or excessive sleepiness 
(Schreck & Mulick. 2000; Wirojanan et al., 2009).    
Sleep onset insomnia. The most common types of sleep problems in children with autism 
problems associated with sleep onset and maintenance (Cortesi et al., 2010; Malow et al., 2014; 
Souders et al., 2009). Children with autism have difficulties in sleep initiation, shorter sleep time, 
and more interrupted sleep patterns when compared to their typically developing peers (Elrod & 
Hood, 2015; Miano et al., 2007). Sleep onset insomnia can include the sleep-onset association type 
or limit-setting type. Children with the sleep-onset association type of behavioural insomnia 
typically depend on a specific stimulus, object, setting, or person to initiate sleep or to resume 
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normal sleep (Souders et al., 2017). Children with limit-setting type of behavioural insomnia 
struggle or refuse to sleep at bedtime because of difficulties dealing with limits set by the caregiver. 
These resistance or refusal behaviours often escalate each night and eventually become disruptive 
(Souders et al., 2017).  
Sleep maintenance problems. Sleep maintenance problems in children with autism include 
frequent night wakings and early morning wakings (Giannotti et al., 2008). Parents report prolonged 
night wakings lasting for up to 2-3 hours wherein the child might get up, laugh, talk, play with toys 
or various objects, and run around (Cortesi et al., 2010; Patzold, Richdale, & Tonge, 1998). Due to 
the difficulty in initiating and maintaining sleep, children with autism might have difficulty 
establishing appropriate sleep-wake cycles and might experience circadian rhythm sleep disorders, 
such as delays in falling asleep, waking early in the morning, feeling tired when awake, and feeling 
sleepy during the day (Taylor, Schreck, & Mulick, 2012).  
Parasomnias. Parasomnias refers to abnormal behaviours associated with sleep such as 
sleepwalking and disorders related to incomplete dissociation of wakefulness from sleep (Howell, 
2012). Parasomnias, such as nightmares and sleepwalking, are less frequently reported in children 
with autism (Williams, Sears, & Allard, 2004). Findings on the prevalence of parasomnias in autism 
are in fact, relatively mixed. Two studies have reported low incidence rates of parasomnias among 
children with ASD (Patzold, Richdale, & Tong, 1998; Williams et al., 2004). In contrast, Schreck 
and Mulick (2000) reported that children with ASD exhibited higher rates of parasomnias when 
compared to typically developing children or children with developmental disabilities or pervasive 
developmental disorder. Liu et al. (2006) also found that all sleep problems, including parasomnias, 
were very prevalent in children with ASD and suggested the possibility of compounded effects of 
multiple sleep problems.  
Sleep-disordered breathing. Sleep-disordered breathing encompasses a spectrum of sleep-
related breathing disorders, including snoring, obstructive sleep apnoea, central sleep apnoea, sleep-
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related hypoventilation and respiratory-related arousals (Mohammadieh, Sutherland, & Cistulli, 
2017).   
Obstructive Sleep Apnoea. Obstructive sleep apnoea refers to conditions in which frequent 
collapse of upper airway during sleep causing recurrent disturbances in gas exchange which lead to 
oxygen desaturations, nocturnal arousal and fragmented sleep (Jordan, McSharry, & Malhotra, 
2014; Mohammadieh et al., 2017). One of the most common symptoms of Obstructive Sleep 
Apnoea in children is snoring (Owen, Canter, & Robinson, 1996). However, both snoring and 
obstructive apnoea are two extremes of a wide spectrum of upper airway resistance. In children with 
obstructive sleep apnoea, in addition to snoring, the parent or caregiver might also comment on 
breathing difficulties during sleep and apnoea. Nonetheless, the clinical presentation of obstructive 
sleep apnoea was usually very nonspecific and a more definitive diagnostic required the use of an 
overnight polysomnographic evaluation (Gozal, 2001). The present study focuses on behavioural 
sleep problems and, therefore, excludes all children with obstructive sleep apnoea.   
Co-sleeping. Co-sleeping is relatively common in children with autism. The high frequency 
of co-sleeping might be due to sleep problems common in children with autism, parental or 
caregiver concerns and the intention to monitor and care for the child if awake during the night, 
difficulties with self-soothing and self-regulating, and difficulties in adjusting to different sleep 
environment (Bastida-Pozuelo, Meltzer, & Sanchez-Ortuno, 2018; Liu et al., 2006). By being 
present at bedtime to reduce sleep onset latency in children with autism, a parent might become a 
negative sleep onset association requiring full night co-sleeping (Bastida-Pozuelo et al., 2018). 
Evidence of an association between co-sleeping and behavioural sleep problems are not clear 
(Mileva-Seitz et al., 2017). A recent longitudinal population-based study of 4,231 children from 
birth until the age of six years found an association between co-sleeping and impaired child mental 
health at the age of six years (Santos et al., 2017). In contrast, an 18-year longitudinal study of 205 
families found no association between co-sleeping and behaviour problems and difficulties in peer 
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and intimate relationships at age of 6 years and age of 18 years old (Okami, Weisner, & Olmstead, 
2002). 
Etiology of sleep problems in children with ASD. Spielman et al. (1987) proposed an 
insomnia model which describes predisposing, precipitating, and perpetuating factors crucial to the 
development and maintenance of insomnia. This includes genetic, physiological, behavioural, 
psychological, and environmental factors (Spielman, Caruso, & Glovinsky, 1987). Predisposing 
factors, such as the neurobiological and neuropsychiatric vulnerability of children with autism 
(Souders et al., 2017), provide differential susceptibility to individuals. Precipitating factors push an 
individual over a hypothetical threshold to produce acute symptoms of insomnia. These 
precipitating factors could include environmental stressors such as changes in sensory stimuli and 
sleep routine, psychological stressors such as difficulties encountered during the daytime, or 
physiological stressors such as sickness (Souders et al., 2017). Perpetuating factors prevent the 
individual from resuming normal sleep. Perpetuating factors, such as parental presence until sleep 
onset or during a daytime nap, could subsequently be introduced by caregivers. Such behavioural 
conditions that are initiated by caregivers to relieve symptoms of insomnia in their children often 
inadvertently worsen the symptoms and perpetuate insomnia long-term (Souders et al., 2017).  
Biological or co-morbidities or medical factors. Biological or medical factors that are 
associated with sleep disorders in ASD include abnormalities in neurotransmitter systems (e.g., 
melatonin, Gamma-Aminobutyric Acid (GABA), and serotonin); medical conditions that disrupt 
sleep (e.g., gastrointestinal (GI) dysfunctions, Obstructive Sleep Apnoea, and epilepsy); and the 
medications taken to treat these conditions (Goldman et al., 2009; Kothare & Kotagal, 2011; Liu et 
al., 2006; McCue, Flick, Twyman, & Xian, 2017). Abnormalities in melatonin secretion are also 
widely reported in earlier studies of sleep in children with autism (Melke et al., 2008; Tordjman et 
al, 2015). Melatonin is a neurohormone that regulates the circadian sleep-wake rhythms (Arendt, 
2003; Tordjman et al., 2013).  
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Medical conditions that disrupt sleep have also been reported in several studies. Significant 
associations have been found between sleep problems and GI dysfunction among children with 
autism (Kang, Wagner, & Ming, 2014; Maenner et al., 2012; Mannion, Leader, & Healy, 2013; 
Ming et al., 2008). In one of the largest studies to estimate the relationship between GI dysfunction 
and sleep problem severity in children with ASD, McCue et al. (2017) found that children with 
autism who had GI dysfunctions had a significantly higher probability of having sleep disorders and 
were twice as likely to experience multiple sleep problems. Several studies have also reported a 
reduction in sleep problems and features of autism following the treatment of medical conditions 
that disrupt sleep. For example, Malow et al. (2006b) reported improvements in autism features, 
such as social communication, repetitive and restricted behaviours, attention, hypersensitivity, and 
sleep after treatment for Obstructive Sleep Apnoea in a 5-year-old female with autism. In a more 
recent study, Murata et al. (2017) reported significant improvement in the features of autism after 
Obstructive Sleep Apnoea treatment in 30 children with autism. Other medical conditions that 
disrupt sleep in children with autism include sleep movement disorders (e.g., restless leg, bruxism, 
stereotypic movements), daytime sleepiness, and epilepsy (Liu et al., 2006; Rodriquez, 2007; 
Schreck & Mulick, 2000).  
Medications, such as psychostimulants and atomoxetine, taken to treat psychopathology or 
the medical conditions, described above, might also disrupt sleep in children with autism (Liu et al., 
2006; Malow et al., 2012; Mayes & Calhoun, 2009; Singh & Zimmerman, 2015). Some 
medications result in side effects such as sedation or insomnia, or long term neurological symptoms 
and disorders (i.e. tardive dyskinesia) (Matson & Hess, 2011; McCue et al., 2017).  
Psychological causes. Externalising behaviour, such as hyperactivity, aggression, 
oppositional behaviour, impulsivity, explosiveness, attention, and impulsivity have been related to 
sleep problems in children with autism (Allik, Larsson, & Smedje, 2006; Hollway & Aman, 2011; 
Malow et al., 2006a; Mayes & Calhoun, 2009). In addition to externalising problems, studies 
reported noticeable affective and emotional problems (i.e., anxiety and depressive symptoms) 
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between autism good and poor sleepers (Allik et al., 2006; Hollway & Aman, 2011; Malow et al., 
2006a) suggesting that emotional difficulties may play a role in the development of insomnia in 
children with ASD (Hollway & Aman, 2011; Malow et al., 2006a). 
Social or familial factors. Social or familial factors may also contribute toward sleep 
problems in those with ASD. This includes problematic sleep-related cognitions, active parental 
involvement and not allowing children to self-soothe. For example, problematic sleep-related 
cognitions (i.e., doubts about parenting competence and difficulties with limit setting) expressed by 
parents or caregivers were associated with disrupted sleep in both typically developing or children 
with autism. Likewise, active parental or caregiver involvement, as opposed to allowing children to 
self-soothe, during transitions from awake to asleep was associated with shorter and more 
fragmented sleep in children with autism (Levin & Scher, 2016). Nevertheless, empirical support 
that linked symptoms of dysregulation, such as sleep problems and somatic complaints, to parent 
behaviours was limited and no study investigated how parent behaviours influence the development 
of dysregulation among children with autism (Wiggins et al., 2018). A more recent study 
investigating the presence of sub-clinical autism characteristics (i.e., broader autism phenotype) in 
families of children with autism found that the presence of broader autism phenotype in parents of 
children with autism was significantly associated with the child having anxiety, depression and 
sleep problems (Rubenstein et al., 2018).  
Environmental factors. Behaviours that promote quality sleep and longer sleep duration 
(i.e. sleep hygiene) play an important role in sleep development and sleep problems in early 
childhood (Sadeh, Tikotzky, & Scher, 2010). Sleep hygiene factors that might contribute toward 
sleep problems in children with autism include issues with the bedroom environment (e.g., 
television, environmental light, loud noises, and temperature), sleep scheduling (e.g., inconsistent 
bedtimes, wake up time and nap times, bedtime routine), food and beverage consumption (e.g., food 
intake immediately prior to bed, caffeinated drinks) and access to highly arousing pre-bedtime 
activities (e.g., use of electronic media devices, such as tablets and mobile phones, exercise 
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immediately prior to bed). Each of these factors can act to precipitate or perpetuate sleep 
disturbances in children with ASD (Akacem, Wright, & LeBourgeois, 2016; Mazurek, Engelhardt, 
Hilgard, & Sohl, 2016; Mindell, Meltzer, Carskadon, & Chervin, 2009; Richdale & Schreck, 2019; 
van der Heijden, Stoffelsen, Popma, & Swaab, 2018).  
A behavioural model of sleep disturbance. Sleep is neither respondent nor operant 
behaviour. It is not a respondent behaviour because it is not possible to consistently elicit sleep by 
presenting the unconditioned stimulus for sleep. It is also not operant behaviour because it is not 
possible to increase and decrease the frequency and duration of sleep by reinforcing or punishing 
sleep (Blampied & France, 1993). Instead, it is a biobehavioural state in which both biological and 
behavioural variables are involved in the initiation and maintenance of sleep. A behavioural model 
of sleep must, therefore, incorporate the relationship between sleep and the variables that are critical 
for both respondent behaviour (conditioned and unconditioned stimuli) and operant behaviour 
(three-term contingencies involving antecedent stimuli, behaviours, and response consequences) 
(Blampied & France, 1993). Although sleep in itself is a state and not a behaviour per se, falling 
asleep is an operant behaviour performed to produce sleep and reinforced by sleep itself (Bootzin, 
1977, as cited in Blampied & France, 1993). In extending this argument further, Ferster et al. (1975) 
suggested an operant behaviour chain that began with bed-preparation behaviours and ended with a 
period of behavioural quietude just before falling asleep. To enable sleep to occur reliably and 
appropriately, Bootzin (1977) assumed that the operant behaviour chains needed to come under the 
control of appropriate discriminative stimuli. Each component of the behaviour chain might have 
different discriminative stimuli and each component might provide the discriminative stimuli for the 
subsequent component of the chain. A period of behavioural quietude enables sleep-preparatory 
cues to be discriminated and facilitate falling asleep. In contrast, continued activity will compete 
and prevent any sleep-preparatory cues to be discriminated and interfere with falling asleep. The 
second key assumption made by Bootzin (1977) was that sleep difficulties might be associated with 
inappropriate and sleep-competing behaviour. These competing behaviours were maintained by 
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various positive and negative reinforcers and might also come under the control of discriminative 
stimuli. Based on the behavioural analysis of sleep mentioned above, Blampied and France (1993) 
proposed two important aspects encompassing the antecedents and consequences associated with 
the bedtime behavioural chain. First, appropriate discriminative stimulus control needed to be 
available for each component of the behavioural chain. Second, the bedtime behavioural chain and 
sleep-promoting behaviours needed to be shaped, strengthened and maintained by contingencies of 
reinforcement. Absence of appropriate discriminative stimulus control might contribute to bed 
refusal and delay in sleep initiation. Furthermore, distinctiveness and consistency of these 
discriminative stimuli might affect the regularity and orderliness with which the bedtime behaviour 
chain is started and completed. These discriminative stimuli could include bed-related cues and self-
produced comfort cues. However, some external cues (e.g., bedtime feeding, pre-bed, and pre-sleep 
rituals) might facilitate falling asleep initially, but might interfere with falling asleep once habitual. 
In addition, behaviour incompatible with going to bed and falling asleep also competed with sleep-
compatible behaviour. The response competition from sleep-compatible and incompatible 
behaviour can be explained by analysis of the contingencies of positive and negative reinforcement 
(Blampied & France, 1993). For children, parental attention was a powerful reinforcer that was 
more immediate and, therefore, more potent than the reinforcer of sleep. For parents, not having a 
child crying and going to sleep at night was likely to be a powerful negative reinforcer. These 
consequences were mutually reinforcing and maintained sleep-incompatible behaviour and 
contributed to the other half of bed refusal and delay in sleep initiation issues mentioned above 
(Blampied & France, 1993). For example, children must learn behavioural quietude, allow the 
naturally occurring bed cues to facilitate falling asleep and subsequently reinforced by sleep. In case 
of sleep-onset delay, children might initially struggle with the period of behavioural quietude and 
will display distress behaviour in an attempt to avoid or escape from such a situation. Any distress 
behaviour is doubly reinforced if it is effective in gaining parental attention. Such behaviour is 
negatively reinforced by escape from the behavioural quietude prior to falling asleep and positively 
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reinforced by immediate parental attention. Both the distress behaviour and subsequent parental 
interaction compete with falling asleep under natural stimulus control and thus aggravating the 
problem. Moreover, such distress behaviour might occur earlier and earlier, while parental attention 
will be gained more and more immediate, resulting in prolonged bedtime tantrums and sleep 
initiations (Blampied & France, 1993). Similarly, in cosleeping, a practice where the child is 
allowed to sleep in the parents’ bed during sleep initiation or upon night wakings, appropriate 
stimulus control could not be developed and contingencies of positive and negative reinforcement 
were involved in maintaining the practice (Blampied & France, 1993). Night wakings might also be 
maintained by similar contingencies. While growing up, an infant is likely to cry in response to 
waking and the parent will attend almost immediately since the immediate parental attention may 
shorten the infant’s crying. Hence, it might be very difficult for parents to withhold their attention in 
order for their child to learn to resume sleep without parental involvement or interaction. 
An assessment of both the clear discriminative stimulus control and contingencies of 
reinforcement that may shape and maintain either appropriate or disturbed sleep is crucial so that 
appropriate natural cues become the controlling stimulus for falling asleep and sleep-compatible 
behaviours are reinforced (Blampied, 2013; Blampied & France, 1993).            
Behavioural factors. Behavioural causes of insomnia (e.g., poor sleep habits) might stem 
from the core behavioural deficits associated with autism which might impede the establishment of 
consistent bedtime routines and habits (Malow et al., 2014). For example, due to deficits in 
communication skills, children with autism might not readily understand bedtime expectations. 
Furthermore, children with autism might have difficulty transitioning from daytime activities and 
calming themselves in preparation to sleep (Malow et al., 2014).  
Biopsychosocial causes. According to Richdale and Schreck (2009) sleep problems in 
children with autism can be the result of a combination of biopsychosocial factors. Specifically, 
they emphasise the complex interaction between biological, psychological or behavioural, and 
environmental factors in sleep problems in children with autism. For example, in children with 
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autism any combination of circadian rhythm dysfunction, reinforcement for sleep interfering 
behaviour, fears or worries about bedtime, or sensitivity to environmental stimuli might interact to 
exacerbate or maintain sleep problems (Souders et al., 2009; Wiggs & Stores, 2004). In addition, 
children with autism are more vulnerable to sleep problems due to prevalent symptoms of 
hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), oppositional defiant disorder 
(ODD) (Allik et al., 2006; Liu et al., 2006; Malow et al., 2006a) and comorbid anxiety and 
depression (Leyfer et al., 2006).  
Bidirectional interaction between biopsychosocial cause and sleep problems. Hollway and 
Aman (2011) have proposed a bidirectional theoretical framework for predicting sleep disturbance 
in children with autism in which vulnerability factors might be associated with sleep problems and 
sleep problems might negatively affect or worsen the biopsychosocial risk or vulnerability factors. 
Intellectual functioning has been found to be a moderator of autism symptom severity and 
ultimately of insomnia in those with autism. Features of autism acted as vulnerability factors and 
predisposed children to insomnia in the presence of environmental stressors. In addition, according 
to the model, each of the autism core symptoms – communication deficits, restricted and repetitive 
behaviour, and social skills deficits – served additively to increase maladaptive coping mechanisms 
such as internalising, externalising, and over-arousal by affecting sleep. Hollway and Aman (2011) 
also found that comorbid medical conditions (epilepsy, GI problems) were associated with sleep 
disturbance. Finally, a bidirectional component was included to show the effect that lack of sleep 
had on maladaptive responding (Hollway, Aman, & Butter, 2013). In the general population, a 
bidirectional relationship between emotional problems and sleep problems had been hypothesised 
(Mulraney, Giallo, Lycett, Mensah, & Sciberras, 2016). Several studies had found that emotional 
problems predicted the onset of sleep problems and that sleep problems predicted the onset of 
emotional problems (Baglioni et al., 2011; Jansson-Frojmark & Lindblom, 2008; Johnson, Roth & 
Breslau, 2006).  
Page 31 of 167  
It should also be noted that the Hollway et al. (2013) study was cross-sectional not 
longitudinal and, hence, directionality and causality cannot be determined (Mazurek & Sohl, 2016). 
In order to determine causal factors, it is important that predictions are made using both baseline 
and follow-up data (Shui, Katz, Malow, & Mazurek, 2018). In a longitudinal study, aimed at 
identifying the bi-directionality of the relationship between sleep problems and ASD, Verhoeff et al. 
(2018) took a population-based sample of 5,151 children who had sleep problems and autistic traits. 
From 1 ½ years onward they assessed sleep problems and autistic traits when the children were 1 ½ 
years, 3 and 6 years old. In addition, sleep problems were assessed again at the age of 9 years old. 
Children’s sleep problems were assessed using the Sleep Problem Scale, a pre-defined Problem 
Scale of the CBCL (Achenbach & Ruffle, 2000). Results showed a significant long-term association 
between autistic traits at age 1.5 and 3 years and more sleep problems at 6 years old. That is, 
children either with autistic traits or with ASD at 6 years old, had more sleep problems at 9 years 
old.  Importantly also, no evidence was found to indicate that sleep problems preceded the 
development of autistic traits in toddlerhood.  The authors concluded that sleep problems did not 
precede and worsen autistic behaviour but rather co-occur with autistic traits in early childhood and 
increase over time in children with autism (Verhoeff et al., 2018)   
Sleep problems and autism symptoms and severity. The association between the severity 
of autism symptoms and reduced night sleeping has been reported in some research studies (Adams 
Matson, Cervantes, & Godlin, 2014; Allik et al, 2006; Cohen et al., 2017; Hoffman et al., 2008; 
Goldman et al., 2011; Mayes & Calhoun, 2009; Patzold et al., 1998; Schreck et al., 2004; Tudor, 
Hoffman, & Sweeney, 2012). Schreck et al. (2004) used the Gilliam Autism Rating Scale (GARS; 
Gilliam, 1995) to measure core autism features and found that shorter sleep duration predicted 
GARS total scores, including Stereotyped Behaviour, Social Interaction, and Total Autism Quotient 
and the GARS Communication domain scores predicted night wakings and sensitivity to stimuli in 
the environment. Furthermore, in a longitudinal study using a dataset of over 50,000 nights of sleep 
obtained from a sample of children with low functioning autism, Cohen et al. (2017) reported that 
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sleep deficits increase with autism symptom severity. Mayes and Calhoun (2009) used the Pediatric 
Behaviour Scale (PBS) to assess both sleep problems and behaviour in a sample of 477 children 
with autism and reported that sleep disturbances were significantly correlated with both 
internalising and externalising behaviours, as measured on the PBS.  
Sleep problems and social interaction and communication difficulties. Research has 
consistently demonstrated that sleep problems are associated with, or predictive of, difficulty 
developing peer relationships, social interaction problems, and communication difficulties (Schreck 
et al., 2004; Tudor et al., 2012; Veatch et al., 2017). Schreck et al. (2004) reported that, among 
fifty-five 5- to 12-year-old children with autism, shorter duration of sleep partially predicted social 
interaction problems and severity of stereotypic behaviours whereas over-sensitivity to stimuli in 
the environment was associated with communication problems and developmental abnormalities 
commonly related to autism (e.g., repetitive behaviours, regression in skill, delays in speech 
development). Consistent with Schreck et al. (2004), in a study of 335 children with autism and IQs 
in the normal range, Taylor et al. (2012) found children who slept more on average per night 
without waking and were less bothered by environmental stimuli in their sleeping environment 
showed better ability to effectively communicate with others during the day.  
Sleep problems and stereotyped and repetitive behaviour. The results from research studies 
that investigated the relationship between the intensity of restricted and repetitive behaviours and 
sleep problems in children with autism were mixed and generally reported that sleep problems were 
related to the presence of higher levels of restricted and repetitive behaviours (Goldman et al., 2009; 
Schreck et al., 2004), although this relationship might be moderated by the level of cognitive ability 
(Gabriels, Cuccaro, Hill, Ivers, & Goldson, 2005). In a study of 109 children with ASD aged 3 to 18 
years old, Tudor et al. (2012) found that sleep onset delay was a predictor of stereotyped behaviour. 
In another study with 2,714 children, Veatch et al. (2017) reported that shorter sleep duration was 
strongly associated with an adherence to restricted and repetitive behaviours and maladaptive 
behaviours. In contrast, Malow et al. (2006) did not find any association between restricted and 
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repetitive behaviour and sleep problems, although the authors suggested that additional studies in 
ASD relating to sleep and daytime behaviours would be needed to validate the findings and 
interventional studies will be necessary to determine causality in relation to sleep and behaviour.   
Sleep problems and adaptive behaviour. Adaptive behaviour is generally defined as an 
individual’s ability to translate cognitive ability into real-life skills such as conversing with and 
understanding others, participating in group and community activities, interacting with others and 
developing relationships, taking care of one’s health, grooming and domestic chores (Klin et al., 
2007; Sparrow & Cicchetti, 1985). There has been limited research into the effects of sleep 
problems on adaptive behaviour in children with autism (Taylor et al., 2012). In one of the first 
studies to investigate the impact of sleep problems on the ability to complete daily living activities, 
Taylor et al. (2012) reported that those children who slept less on average both at night and during 
the day had more difficulty with all adaptive behaviour tasks, especially motor and social skills. A 
more recent study by Cohen et al. (2017) that used hierarchical cluster analysis, based on an 
unprecedentedly large dataset of over 50,000 nights sleep for 106 children and adolescence aged 
between 5 and 18 years old, who had low functioning autism, also reported that children with 
reduced sleep duration, early morning wakings and irregular sleep timing exhibited greater 
impairments in adaptive functioning, as measured by the Vineland Adaptive Behaviour Scales 
(VABS; Sparrow, Balla, & Cicchetti, 1984). Furthermore, Krakowiak et al. (2008) reported that, 
lower adaptive function was associated with increased difficulties with sleep onset, night waking, 
and shorter duration of sleep. However, adaptive functioning difficulties did not predict the severity 
of either type of sleep problem or the duration of sleep (Krakowiak et al., 2008).  
Sleep problems and externalising behaviour. Sleep problems in children with ASD have 
been strongly linked with rates of aggression, self-injury, tantrums, and hostility/irritability (Adams, 
Matson, & Jang, 2014; Allik et al., 2006; Bruni et al., 2007; Cohen et al., 2018; Goldman et al., 
2011; Mazurek & Sohl, 2016; Patzold et al., 1998; Shui et al., 2018). In a sample of 1,784 children 
with autism, Goldman et al. (2011) found that poor sleepers (as reported by parents) demonstrated 
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greater challenging behaviour, including aggression and self-injurious behaviour, than good 
sleepers. Mazurek and Sohl (2016) reported that, of the different types of sleep problems, night 
wakings were strongly and positively correlated with physical aggression and hostility/irritability. A 
recent longitudinal study based on a sample of 67 children aged 6.6 to 19 years old with low 
functioning autism, by Cohen et al. (2018) found that longer duration of prior sleep predicted 
subsequent daytime challenging behaviour such as aggression, self-injury, and tantrums. 
Furthermore, another longitudinal study of 1,045 children and adolescence with autism without 
sleep problems at baseline aged 2 to 17 years old, Shui et al. (2018) reported that aggressive 
behaviour at baseline might also predict poor sleep one year later. 
Sleep problems and hyperactivity and inattention. A number of studies have reported an 
association between sleep problems and hyperactivity and inattention in children with ASD (Allik 
et al., 2006; Cortesi et al., 2010; Goldman et al., 2009; Kothare & Kotagal, 2011; Malow et al., 
2006a; Mayes & Calhoun, 2009; Mazurek & Sohl, 2016). For example, more hyperactivity in 
children with autism who were poor sleepers than those who were good sleepers and typically 
developing children (Goldman et al., 2009; Malow et al., 2006a). Of the type of sleep disturbance, 
sleep anxiety was positively correlated with both irritability and hyperactivity (Mazurek & Sohl, 
2016). Nevertheless, results from a longitudinal study showed that sleep disturbance did not predict 
hyperactivity one year later for children with high functioning ASD aged 7 to 12 years old (May, 
Cornish, Conduit, Rajaratnam, & Rinehart, 2015) suggesting that no bidirectional relationship 
between sleep problems and hyperactivity.    
Sleep problems and internalising behaviour. Results from studies that investigated the 
relationship between internalising behaviours and sleep problems have demonstrated that sleep 
problems have been strongly associated with anxiety and depressive symptoms (Allik et al., 2006; 
Malow et al., 2006a; May et al., 2015; Patzold et al., 1998; Sikora et al., 2012). Comparing the 
results from the Affective subscale of the CBCL between children with autism who were poor 
sleepers and good sleepers, Malow et al. (2006) found that poor sleepers had significantly more 
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depressive symptoms. In addition, some children with autism experienced significant depressive 
symptoms which affected sleep (Malow et al., 2006a). In a longitudinal study investigating the 
predictive associations between sleep disturbance and behavioural or emotional problems, May et 
al. (2015) reported sleep disturbance predicted anxiety one year later although the sample was 
limited to 7- to 12-year-old children with high functioning autism.   
Common treatments for sleep problems in children with ASD. The two most commonly 
used treatment methods for children with ASD are melatonin and behavioural interventions. Each of 
these treatment approaches is outlined below.  
Melatonin. The literature indicates that melatonin is an effective intervention for sleep 
problems individuals with ASD (Garstang & Wallis, 2006; Gringas, Nir, Breddy, Frydman-Marom, 
& Findling, 2017; Guenole & Baleyte, 2011; Guenole et al., 2011; Hollway & Aman, 2011; Malow 
et al., 2012; Maras et al., 2018; Rossignol & Frye, 2011; Wright et al., 2011). For example, placebo-
controlled trials of 11-20 children with ASD, aged 4 to 16 years old, showed improvements of 
longer sleep latency and increased total sleep duration under melatonin compared to a placebo 
(Garstang & Wallis, 2006; Wright et al., 2011). In a more recent randomized, double-blind, 
placebo-controlled trial conducted with children aged 2 to 17.5 years old in US (n = 196) and in 
Europe (n = 71), a paediatric-appropriate prolonged-release melatonin was shown to be more 
effective in children with ASD than placebo in increasing total sleep time and reducing sleep 
latency. Treatment-related adverse events such as somnolence and mood swings were reported in 
11.7% and 1.7% of the treatment group, respectively. In comparison, somnolence and mood swings 
affected 3.1% and 6.2% of the placebo group, respectively. Severe adverse events such as agitation 
and fatigue were reported in 8.3% and 6.7% of the treatment group, respectively. In comparison, 
agitation and fatigue affected 4.6% and 3.1% of the placebo group, respectively (Gringas et al., 
2017). In a subsequent follow-up study, 52 weeks later, on those children who completed the initial 
13-week in Gringras’ (2017) trial, paediatric-appropriate prolonged-release melatonin continued to 
show effectiveness in increasing total sleep time, reducing sleep latency and night wakings. Fatigue 
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and mood swings were reported in 5.3% and 3.2% of treatment group, respectively (Maras et al., 
2018). Although severe adverse events such as fatigue had decreased from 6.7% to 5.3% of the 
treatment group, treatment-related adverse events such as mood swings had almost doubled from 
1.7% to 3.2% of the treatment group highlighting the limitations of melatonin. Furthermore, parents 
of children with ASD preferred behaviourally-based interventions over medications (Williams et al., 
2004).  
Behaviourally-based interventions. Behaviourally-based interventions for sleep problems in 
children with ASD have been widely researched (Brown, Kuo, Phillips, Berry, & Tan, 2013) and 
can be organised into two major categories – antecedent-based and consequence-based procedures 
(Turner & Johnson, 2012).  
Antecedent-based procedures. In young children with ASD, antecedent-based procedures 
have been used to address delayed sleep onset and night wakings (Delemere & Dounavi, 2018; 
DeLeon, Fisher, & Marhefka, 2004; Durand & Christodulu, 2004; Durand, 2002). Examples of 
antecedent-based procedures are bedtime fading interventions, sleep restriction procedure, and 
scheduled awakening procedure. In bedtime fading interventions, a bedtime is chosen closer to the 
time when the child is naturally fall asleep. This bedtime is observed until sleep onset occurs within 
a few minutes of the bedtime. Bedtime fading was found to reduce night wakings, increase total 
sleep duration and decrease sleep onset latency for young children with ASD (DeLeon et al., 2004; 
Delemere & Dounavi, 2018). In a sleep restriction procedure, parents or caregivers are requested to 
temporarily reduce children’s total sleep time such that the child is in bed for only 90% of the total 
amount of usual reported sleep time. Once appropriate sleep behaviour is achieved, the sleep 
restriction is removed so that the total amount of sleep is aligned with a developmentally-
appropriate norm. Sleep restriction appeared to result in a reduction of night wakings and 
elimination of sleep disturbances in young children with ASD (Durand & Christodulu, 2004). In  a 
scheduled awakening procedure, parents or caregivers are requested to wake the child 15 minutes 
before the reported spontaneous time of night waking. Parents would then respond to the child as if 
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the night waking happens spontaneously. Over time, the scheduled awakening is gradually and 
systematically faded to occur at a longer interval of uninterrupted sleep until the intervals between 
night wakings are longer in duration. Scheduled awakening increased total sleep time for two out of 
three children with ASD (Durand, 2002). So far, scheduled awakenings only meets the criteria to be 
considered possibly efficacious with more research needed. To be considered probably efficacious 
or well-established interventions, more replications of existing studies are needed (Vriend et al., 
2011).     
Sleep hygiene. Sleep hygiene modification is another example of an antecedent based 
modification and has been shown to be an effective intervention for sleep problems in children with 
ASD. Common sleep hygiene recommendations include selecting a suitable and consistent bedtime 
and wake time, establishing a positive and consistent bedtime routine, and reducing 
emotional/behavioural stimulation at night. In addition, addressing sensory hypersensitivity 
associated with stimuli such as noises or tactile sensitivity to clothes and blankets in the sleep 
environment might help improve sleep quality (Cortesi et al., 2010). A more recent study by van der 
Heijden et al. (2018) reported that sleep problems in children with ASD were related to inadequate 
sleep hygiene while, in typically developing children, sleep problems were related to both 
chronotype and inadequate sleep hygiene. The authors suggested that sleep hygiene improvement 
might be effective in children with ASD and proposed that treatment strategies for sleep problems 
should focus initially on sleep hygiene improvements. However, the authors also found that the 
negative effects of inadequate sleep hygiene seemed to be diminished by the presence of comorbid 
anxiety or depression and cautioned that more research was needed to understand the interplay of 
sleep hygiene, anxiety/depression, and sleep problems in ASD (van der Heijden et al., 2018).  
Consequence-based modifications. Consequence-based modifications involve manipulating 
reinforcement so as to shape and maintain a desirable behaviour and reduce undesirable behaviour. 
Examples of consequence-based interventions are standard extinction and modified extinction 
procedures (Turner & Johnson, 2012). In standard extinction procedures, parents are advised to 
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avoid any interaction with the child after they bid their child goodnight, unless absolutely necessary 
for safety reasons (Vriend et al., 2011), in order to eliminate parental attention that may be 
reinforcing the sleep problem (Mindell, 1999). While extinction procedures are effective, an 
extinction burst might occur in which negative behaviours might temporarily increase before an 
improvement is observed. As a result, education on extinction bursts and support given to parents 
during the procedure is crucial to help increase parental adherence to treatment and thereby the 
possibility of improvement. A modified version of extinction offers an alternative solution. 
Examples include the minimal check procedure in which regular checking is performed by parents 
or caregivers throughout an extinction procedure (France & Blampied, 2005; Richdale & Wiggs, 
2005) or graduated extinction in which challenging behaviours are gradually reduced through 
gradual withdrawal of reinforcement over time (Singh & Zimmerman, 2015; Wiggs & France, 
2000). In this modified approach, instead of eliminating interaction with the child throughout the 
night, parents are advised to ignore bedtime disruptions for a predetermined length of time. At the 
end of that time, if the bedtime disruptions persist, parents will settle the child back in bed but the 
interaction will be at a minimum (Vriend et al., 2011). Studies had found standard or graduated 
extinction to be effective for children with ASD in reducing bedtime resistance, night wakings, 
sleep onset delay, co-sleeping (Montgomery, Stores, & Wiggs, 2004; Reed et al., 2009; Weiskop, 
Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews, 2005). Furthermore, reduction in 
night wakings and bedtime resistance were maintained at 6- and 12-month follow-ups (Montgomery 
et al., 2004; Weiskop et al., 2005). To date, only extinction meet the criteria for a possibly 
efficacious intervention requiring more research (Schreck, 2001) and more replications are needed 
for interventions to be considered probably efficacious or well-established (Vriend et al., 2011).   
Functional Behavioural Assessment (FBA) interventions. Given that the number of variables 
which initiate or exacerbate sleep problems are unique and different for each individual, 
understanding these individual-specific variables is crucial for effective treatment formulation and 
implementation. Functional behavioural assessment (FBA) is a process commonly used to identify 
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the antecedents (context or setting), consequences (e.g., parent attention or responses), and the 
function of a specified problem behaviour (the sleep problem). Treatment plans developed based on 
the outcomes of FBA are more effective because the intervention plans addressed the individual-
specific variables that initiated and maintained the behaviour (McLay, France, Blampied, Danna, & 
Hunter, 2017). Despite strong evidence to support the use of FBA to inform interventions for 
challenging behaviour (Beavers, Iwata, & Lerman, 2013; Hanley, Jin, Vanselow, & Hanratty, 2014) 
and sleep problems (Jin, Hanley, & Beaulieu, 2013; McLay et al., 2017), there is very little research 
documenting the FBA process from assessment through to treatment (McLay et al., 2017). Given 
the multiple individual-specific variables that might impact sleep disturbance, information from the 
behaviour assessment and functional analysis part of the FBA needs to be integrated into a coherent, 
albeit tentative, account of the problem, and then linked with a comprehensive and individualised 
treatment plan that can be implemented by parents or caregivers (Blampied, 2013).   
Two of the essential component of FBA informed interventions are elimination or 
modification of sleep-competing antecedent and consequence variables and determination of the 
function of the undesirable behaviour (McLay et al., 2017). Based on a sample of 3 young children, 
2 of whom had been diagnosed with ASD, Jin et al. (2013) demonstrated the efficacy of 
individualised function-based sleep interventions for young children. Behavioural assessment was 
guided by the Sleep Assessment and Treatment Tool (SATT; Hanley, 2005). SATT is an open-
ended interview designed to identify specific sleep problems and the environmental variables that 
triggers the sleep problems. Specific problems and environmental variables asked during the 
interview include: history of the child’s sleep problems; target sleep goals (e.g., bedtime, wake-up 
time); identification of specific sleep problems (e.g., delayed sleep onset, night wakings, issues with 
sleep hygiene and bedtime routine, early morning wakings), description of antecedent conditions 
and consequences or responses; identification of the child’s current bedtime and sleep dependencies 
(i.e., those events, interactions, items that appear to promote sleep); identification of possible sleep 
interfering behaviours and the corresponding reinforcers; and descriptions of treatment options 
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available to the parents or caregivers. By utilising SATT, researchers were able to formulate a 
hypothesise about the functions of sleep interfering behaviours and to evaluate environmental 
contingencies maintaining the child’s sleep difficulties. Treatments include procedures to enhance 
the discriminative stimuli and establishing operations for behavioural quietude and to weaken the 
reinforcers for sleep interfering behaviours. For example, delayed sleep onset was shortened by 
increasing the value of sleep through adjusting the child’s bedtime in accordance to developmental 
norms and their current sleep phases. Sleep interfering behaviours are reduced by eliminating the 
contingency between the sleep interfering behaviour and its reinforcers and providing access to the 
reinforcers prior to bedtime and independent of the interfering behaviour. Night wakings were 
addressed by eliminating inappropriate sleep dependencies (e.g., conditions that were available only 
at bedtime) and gradually establishing sleep dependencies on events that were available both at 
bedtime and throughout the night (Jin et al., 2013).  
In another example, Friedman and Luiselli (2008) reported an effective intervention that 
eliminated excessive daytime sleep in a child with ASD. By using FBA, the authors hypothesised 
that the reported daytime sleep was maintained primarily by automatic reinforcement and might 
have functioned to escape or avoid nonpreferred interactions. In order to eliminate antecedent and 
consequence events that lead and reinforce daytime sleep, a number of procedures were combined, 
including removing sleep-associated stimuli; interruption and redirection to preferred and highly 
stimulating objects and activities upon detection of sleepiness; and positive reinforcement through 
positive interactions and delivering praise for appropriate behaviour alternative to excessive 
daytime sleep (Friedman & Luiselli, 2008).  
A more recent study, utilising FBA to treat sleep problems in a child with ASD, by McLay 
et al. (2017) reported a reduction in the frequency of curtain calls (i.e. behaviours intended to avoid 
or delay going to bed), reduction in frequency and duration of night wakings, reduction in bedtime 
resistance, and reduction in sleep onset delay. Based on FBA, multiple antecedent and consequence 
variables were identified as contributing towards sleep problems. Inadequate sleep hygiene was 
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identified as the antecedent variables that appeared to affect sleep. Consequence variables identified 
to be reinforcing sleep onset delay and night wakings seemed to be breastfeeding, parental attention, 
comfort that came from co-sleeping, social interaction while awake, and access to food and water. 
In addition, the mother’s presence in bed seemed to act as stimulus control for breastfeeding 
demands. Upon completion of the assessment and formulation of treatment plan, additional factors 
were identified during the treatment implementation requiring modifications to the original 
treatment plan. For example, although breastfeeding was initially identified as reinforcer for night 
wakings, eliminating night-time breastfeeding did not eliminate night wakings prompting the re-
evaluation of breastfeeding as the reinforcer. Ultimately, social attention gained during 
breastfeeding was identified as the true primary reinforcer. Another change was made to the 
treatment plan because the child started having a bowel motion immediately upon being put to bed 
requiring the addition of toileting strategy as part of bedtime routine (McLay et al., 2017). Together 
with Jin et al. (2013) study, the study by McLay et al. (2017) provided yet another crucial example 
of the very few studies that have synthesised antecedent and consequence variables together with 
function-matching assessments to create comprehensive and socially valid treatments for sleep 
problems in children with ASD based on the individualised outcomes of FBA.  
In summary, evidence for effective behaviourally-based treatments on sleep problems in 
children with ASD is limited. The heterogeneity of ASD symptoms and high rate of comorbidity 
presents challenges in conducting research in this area. In addition, given that there seemed to be a 
relationship between sleep problems and ASD symptomatology and that considerable differences in 
level of functioning and symptom expression were found in children with ASD, certain degrees of 
treatment individualization are necessary. These modifications provide further challenges on the 
replicability of treatments and might contribute to the limited evidence of effective treatments 
(Vriend et al., 2011).  
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Case Complexity and Treatment Responses  
 Evidence of positive treatment effects for FBA interventions focusing on multiple 
components of sleep topography is available in the literature (Friedman & Luiselli, 2008; Jin et al., 
2013; McLay et al., 2017; Papadopoulos et al., 2015; Reed et al., 2009; Vriend et al., 2011); 
however, given the complex array of factors contributing toward sleep problems in children with 
ASD, further replication of these outcomes is necessary (McLay et al., 2017). The complex array of 
factors contributing toward sleep problems could also be viewed as factors that can potentially 
complicate treatment (Delgadillo, Huey, Bennett, & McMillan, 2017). Hence, identification and 
understanding of this complex array of factors are critical steps in facilitating future replication 
studies. Afterall, complex cases require interventions guided by formulations that account for 
obstacles to improvement (Tarrier, 2006). Understandably, the complex array of factors not only 
encompass the children (child complexity factors) but also the parents or caregivers (family 
complexity factors). Common complexity factors had been identified through a survey of 
practitioners (psychologists and psychiatrists) who worked with children in clinical setting (Kazdin, 
Siegel, & Bass, 1990, as cited in Kazdin & Whitley, 2006). Common child complexity factors are 
comorbidity of other disorders commonly observed in children with ASD and the scope and 
severity of dysfunction. Common family complexity factors are parent dysfunctions (e.g., ASD, 
depression or other disorders), parental stressors in relationship, socio-economic disadvantage of 
the family (Kazdin & Whitley, 2006).      
Kazdin and Whitley (2006) investigated the relationships between treatment outcomes and 
comorbidity and complexity of cases in 183 clinically referred children who met criteria for 
oppositional defiant disorder (also referred to as ODD by some sources) and 132 clinically referred 
children who met criteria for conduct disorder (also referred to as CD by some sources). In the 
study, complexity was determined using a number of factors, including scope of symptoms 
exhibited by the child, academic impairment, history of clinical problem, socioeconomic 
disadvantage of the family, parent and family functioning, and obstacles in coming to treatment. 
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Comorbidity was measured by the number of additional disorders diagnosed in the children and 
number of symptoms that were present across all disorders. These symptoms might capture 
problems that were clinically significant but might not be apparent enough to trigger a diagnosis. 
The authors found that children with greater comorbidity showed significantly greater therapeutic 
change than children with no or only one comorbidity. Children who displayed more symptoms 
across all diagnoses showed greater therapeutic change. Hence, comorbidity did not diminish the 
degree of therapeutic change; however, in terms of treatment outcomes, children with greater 
comorbidity or more symptoms across all diagnoses did not have a different treatment outcome 
compared to those with fewer comorbidity or symptoms. The authors then evaluated case 
complexity through four domains: scope and severity of child dysfunction, parent and family 
functioning, socioeconomic disadvantage, and barriers that emerged during treatment. Scope and 
severity of child dysfunction included total number of symptoms from the diagnostic interview, 
history of academic delays and history of antisocial and delinquent behaviour, frequency of 
delinquent acts in the past year and overall measures of aggression. Parent and family functioning 
factors included parent dysfunction and psychopathology, parental stressors, and family relationship 
issues. Socioeconomic disadvantage was included due to its association with many complexities of 
living, difficulties in managing daily routines and receiving support services. Barriers that emerged 
during treatments included perceived challenges associated with the treatment, poor relationship 
with the therapist and perceived irrelevance of the treatment (Kazdin, Holland, & Crowley, 1997). 
The authors found positive associations between scope and severity of child dysfunction and 
therapeutic change. More severely dysfunctional children responded better to treatment. An 
association was only found between overall parent stress and therapeutic change. Children whose 
parents showed greater stress at pre-treatment displayed greater therapeutic change. No association 
was found between socioeconomic disadvantage, and therapeutic change, that is, no difference in 
treatment responses was observed for more disadvantaged cases. Finally, in terms of barriers to 
treatment, responses to treatments were less for children whose parents experienced greater barriers 
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in treatment participation. In conclusion, although comorbidity was positively associated with 
therapeutic change, children with more comorbidities did not exhibit different treatment outcomes 
at posttreatment compared to other children. Furthermore, excluding barriers associated with 
treatment participation, other domains of case complexity did not weaken the treatment effects 
(Kazdin & Whitley, 2006).     
 Other barriers associated with treatment participation could stem internally from the 
individual. ASD-related impairments in cognition, communication, and self-regulation could affect 
the level of participation in various activities and ultimately affect individual’s gain from such 
activities. In one study, Miller et al. (2016) analysed Participation and Activity Limitation Survey 
(PALS) data on children with neurodevelopmental disorders/disabilities (NDD/D) (ages 5 to 14; 
weighted n = 120,700) in order to investigate the relative roles of an individual’s NDD/D related 
functional characteristics in explaining treatment outcomes. Parental reports were obtained 
regarding the individual’s difficulties in respective functional areas: communication, learning, and 
limitations due to a psychological, or behavioural, emotional condition. Difficulties with reciprocal 
social interactions were estimated by using questions on cognitive limitations due to the presence of 
a developmental disability or disorder, such as ASD, Down syndrome, or mental impairment caused 
by a lack of oxygen at birth. Results showed that ASD-related functional characteristics 
(particularly, impairments in cognition, learning, communication, regulation of emotions and 
behaviour) which explained individual’s participation in various activities (Miller, Masse, Shen, 
Schiariti, & Roxborough, 2013) could possibly lead to the different levels of barriers to treatment. 
Similarly, another study reported that children’s play, social and self-stimulatory behaviours 
predicted the children’s responses to behavioural treatment programme and, ultimately, 
improvements in the areas of language, play, and social skills (Sherer & Schreibman, 2005). In this 
study, the authors identified and tested potential predictor variables of children’s responsiveness to 
a widely used behavioural treatment programme – pivotal response training (PRT; Koegel, et al., 
1989). The authors analysed archival data of 11 children who received a diagnosis of ASD to 
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identify specific child characteristics that were present at intake and that might be predictive of 
treatment outcome. Based on child play behaviours, social behaviours, and self-stimulatory 
behaviours, two distinct behavioural profiles were formulated. The responder profile was 
formulated based on the behavioural profiles of children who responded well to PRT. These 
children tended to exhibit, at the onset, a moderate-to-high interest in toys, had an approachable 
behaviour, had moderate-to-high rates of verbal stereotypy, and had low-to-moderate rates of 
nonverbal self-stimulatory. In contrast, the non-responder profile was formulated based on the 
behavioural profiles of children who did not respond well to PRT. These children showed limited 
toy play, approach behaviours and verbal self-stimulatory behaviours. In addition, these children 
exhibited moderate levels of avoidant behaviour and nonverbal self-stimulatory behaviour at intake. 
The responder and non-responder behavioural profiles were used to select and then predict 
treatment outcomes on six participants – three who matched the responder profile and three who 
matched the non-responder profile. As predicted, participants with the responder profile exhibited 
improvements in the areas of language, play, and social skills. Participants with the non-responder 
profile did not show any improvement. Given that PRT was play based and focused on areas of the 
child’s developments including motivation, response to multiple cues, initiation of social 
interactions, and self-management (Autism Speaks Incorporated, 2018), the authors showed that 
behavioural profiles formulated based on specific behaviours – functional play, approach 
behaviours, avoidant behaviours and self-stimulatory behaviours – could be used as a predictor for 
treatment outcomes. Nevertheless, the authors noted that, based on parent reports, children with a 
non-responder profile in the study responded well to intensive home-based discrete trial training 
(DTT; Lovaas, 1987). Hence, the non-responder profiles proposed in the study was specific to PRT 
only and might not indicate the general responsiveness to other treatment programmes. 
Interestingly, in an earlier study by Koegel et al. (2003), non-responder children with ASD 
demonstrated a favourable response to treatment after completing training to self-initiate (Koegel, 
Carter, & Koegel, 2003). 
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Building on the responder profile identified in the Sherer and Schreibman (2005) study, 
Fossum et al. (2018) investigated the generality of the responder profile and incorporated child 
affect as a potentially important variable. The authors reported that better baseline expressive 
language and cognitive abilities, more positive affect and appropriate toy contact, and lower levels 
of social avoidance and stereotyped/repetitive vocalisations were the characteristics of children who 
gained the most from the treatment (Fossum, Williams, Garon, Bryson, & Smith, 2018). The recent 
Fossum et al. study (2018) supported the behavioural features of children who responded to the 
PRT treatment despite the differences in terms of age range and level of cognitive functioning and 
verbal ability that study and the original Sherer and Schreibman (2005) study. Most importantly, the 
inclusion of positive affect in the responder behavioural profile in the recent study pointed to the 
possibility that positive affect served as an indicator of the child’s motivation for learning (Koegel 
et al., 1998; as cited in Fossum, 2014) that might facilitate the therapist’s work by providing an 
indication of what activities or rewards can be used to greatest advantage for promoting 
communication (Fossum et al., 2018).  
In conclusion, this study intends to contribute to the identification and understanding of case 
complexity in treatment formulation and selection for sleep problems in children with ASD. In the 
following chapter, a literature review will be performed to obtain conceptual clarity and literature 
evidence surrounding this topic.  
 
  





The purpose of this literature review is to explore child-specific complexity factors that may 
serve as predictor variables for treatment responses. Although in the context of child therapy, 
parent- and family-specific complexity factors are a significant part of the equation, the focus of this 
study will be on the child-specific factors. A separate and concurrent study, that does not form part 
of this thesis, examines the parent- and family-specific factors.  
In the present study, the hypothesis that is evaluated is that the complexity of a case 
influences the effectiveness of an evidence-based treatment for sleep problems in children with 
ASD and that the greater the child complexity the less responsive children may be to a behavioural 
sleep treatment programme. There are no standardised ways of assessing case complexity and 
complexity can include an almost infinite set of factors. Despite this many of the factors could be 
identified through an examination of the limited existing research, parental or caregiver reports and 
from clinical processes. These case-specific complexity factors include the scope and severity of 
dysfunction, severity of sleep problems, comorbidity with other disorders, and medications taken to 
address ASD and other symptoms and is largely based upon those factors identified by Kazdin and 
Whitley (2006). 
Search Process 
A systematic search was conducted to identify relevant studies investigating associations 
between biological, developmental, and psychopathological characteristics and outcome of 
treatments for sleep problems in children with ASD. The following databases were included in the 
search: PsycINFO, PsycARTICLES, ScienceDirect, PubMed/MEDLINE (Ovid), and ProQuest. In 
addition, the reference lists of obtained articles, systematic reviews, and meta-analyses were read to 
identify any additional articles that were relevant to the review and not found in the above 
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databases. Searches were limited to those articles that were written in the English language, 
published in a peer-reviewed journal, and that included participants 18 years of age or under.  
The search strategy addressed key search terms for sleep issues, characteristics of 
complexity and treatment outcomes. More specifically, searches were conducted using a 
combination of the following key terms: sleep (disturbance, problems, difficulties, phenotype), 
diagnostic (Autism Spectrum Disorder, autism), characteristics (characteristics, complexity, 
phenotype, subgroup, dimension), and treatment outcome keywords: response, treatment response, 
outcome, treatment outcome. Age-related key terms such as child were not included in the search 
phase to avoid missing studies that did not include age-related terms in the title of the study or that 
used specific terms (e.g., pre-schoolers). Titles and abstracts were screened for relevance and 
content.   
Children and Adolescent Characteristics and Treatment Responses  
Whilst there is strong evidence linking sleep problems and the child comorbidity and 
complexity (i.e. scope and severity of ASD) in children with ASD, limited research has been 
conducted to investigate the impact that these variables have on children’s response to 
interventions, including those that are targeting sleep problems. Several studies have investigated 
the association between child characteristics and the outcome of behavioural intervention in general. 
For example, multiple studies have been conducted to investigate the association between 
individual characteristics and responses to early intensive behavioural interventions (EIBI). In many 
cases, it was found that treatment response was related to child characteristics as opposed to the 
amount or type of intervention (Eaves & Ho, 2004).  
Strauss et al. (2013) performed a comprehensive synthesis of six meta-analyses of EIBI for 
children with ASD published from 2009 to 2011 (Eldevik et al., 2009; Makrygianni & Reed, 2010; 
Peters-Scheffer, Didden, Korzilius, & Sturmey, 2011; Reichow & Wolery, 2009; Virues-Ortega, 
2010). All treatment programmes in the meta-analyses were based on applied behaviour analysis 
with varying definitions – from EIBI based strictly on the Lovaas (1987) method to broader 
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definitions of comprehensive treatment programmes including Pivotal Response Treatment and 
Group Intensive Family Training. Several variables were analysed to identify whether they related 
to treatment outcome. This included pre-intervention characteristics (e.g., IQ, language skills, 
adaptive functioning, severity of ASD symptomatology), chronological age, gender, increase in IQ 
or skill acquisition during treatment, and treatment characteristics (intensity and duration of 
treatment, treatment supervision, supplement treatment and parent involvement). The results of this 
meta-analysis were mixed. Magiati et al. (2007) found that pre-intervention characteristics (i.e. 
initial IQ combined with language skills) was the strongest predictor of treatment outcome. 
However, two studies found that pre-intervention characteristics (i.e. initial IQ alone) does not best 
predict outcome but increase in IQ scores during treatment progress predicted outcomes (Ben-
Itzchak, Lahat, Burgin, & Zachor, 2008; Sallows & Graupner, 2005) 
More recent studies across various EIBI models continued to show possible associations 
between treatment responses and pre-treatment factors such as symptom severity, imitation, and 
functional use of objects (Vivanti et al., 2013), adaptive skills (Flanagan, Perry, & Freeman, 2012), 
and play skills (Kasari, Gulsrud, Freeman, Paparella, & Hellemann, 2012). Importantly, Eapen et al. 
(2013) suggested that the genetic and phenotypic heterogeneity inherent in ASD might prevent a 
single EIBI treatment from being universally effective and many nuanced treatment approaches 
may be required (Eapen et al., 2013).  
Age at baseline and treatment responses. From a behavioural and developmental theory 
perspective, it could be argued that starting Intensive Behavioural Intervention (IBI) at a younger 
age might be beneficial (Perry et al., 2011). It had been suggested that a period of development 
exists before the age of 4 during which early interventions aimed at stimulating young children at 
risk for ASD can substantially change the course of both brain and behavioural development (see 
Dawson, 2008). Studies that have examined response to treatment in children across age-ranges 
have typically found better treatment outcomes for younger children when compared to older 
children (Flanagan et al., 2012; Granpeesheh, Dixon, Tarbox, Kaplan, & Wilke, 2009; Harris & 
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Handleman, 2000; Mandell et al., 2013; Perry et al., 2011). For example, in a community-based 
study for children with autism, aged 3.5- to 4.5-year-old, comparing 61 children who received IBI 
and 61 individually matched children from a waitlist comparison group, Flanagan et al. (2012) 
reported that initial age is an important predictor of better outcomes in IBI relative to the 
comparison group. In another community-based study for children with autism with a wider age 
range (aged 2-7 years), Perry et al. (2011) reported that children who were most successful in the 
program were under 4 years of age at program entry. Using a sample of older children, aged 5- to 8-
year-old, Mandell et al. (2013) investigated the efficacy of a classroom-based intervention for 
children with ASD in a randomized field trial of 119 students and reported that each additional year 
of student age was associated with  a decrease in treatment outcome. In contrast, in a study of a 
similar classroom-based intervention for children with ASD using a sample of 191 children aged 5- 
to 8-year-old, Pellecchia et al. (2015) reported that increased child age was not associated with 
differences in outcome. However, given the data used in the Pellecchia’s (2015) study were selected 
from the third year of a larger intervention study, the authors suggested that involvement in the 
intervention study during the previous years might have affected the association between student 
age and outcome because (1) skills of teaching older children with autism might have improved, (2) 
older children might have reached their maximum response to interventions if they had been 
receiving intensive intervention for several years, and (3) there were more higher functioning older 
children in the third year of the invention than in previous years. Other studies also reported no 
association between initial age and treatment outcome (Eikeseth, Smith, Jahr, & Eldevik, 2007; 
Makrygianni & Reed, 2010; Vivanti et al., 2013). Nevertheless, with the exception to the 
Pellecchia’s (2015) study, all the other studies had a small sample size (n <30). Clear association 
might not be detected due to several reasons, including specific selection criteria, a relatively 
narrow age range at intake, and a small sample size (Flanagan et al., 2012; Perry et al., 2011). In 
summary, the precise nature and power of age as a predictor for IBI treatment outcomes remained 
less obvious (Matson & Smith, 2008). Similarly, given that sleep problems of children with ASD 
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were more likely to persist as they aged and sleep problems were reported to peak around the age of 
6 to 9 years old (Hodge et al., 2014; Krakowiak et al., 2008), it can be reasonable to assume 
different responses to treatment would exist depending on the age of the treatment group.  
Adaptive behaviour at baseline and treatment responses. For children with ASD, some 
critical adaptive behaviours include the capacity for conversing with and understanding others, 
interacting with others, developing relationships, and participating in group activities (Klin et al., 
2007). Studies had suggested distinct sleep patterns based on the developmental trajectories of 
adaptive behaviours in children with ASD (Anderson, Oti, Lord, & Welch, 2009; Baghdadli et al., 
2012; Cohen et al., 2017). Anderson et al. (2009) conducted a longitudinal study of 93 children with 
ASD to examine prospectively the development of adaptive social skills between ages 2 to 13. All 
children received parent-implemented behavioural therapy (e.g., speech therapy, ABA, parent-
implemented structured teaching). Two distinct growth rates of adaptive skills in the domains of 
social and communicative skills were found over time. One group of children showed dramatic 
increases in social skills over time, with VABS scores improving to near age norms for typical 
development by the age of 13 – an average increase of about 8 years, 11 months over the 11-year 
period. This group of children exhibited stronger expressive but not receptive language skills at age 
2. The second group of children showed a much more modest increase in adaptive social skills – 
with an increase of 21 months over the 11-year period. In another longitudinal study of 152 children 
with ASD, aged 3.6- to 6-year-old, over a 10 year period, Baghdadli et al. (2012) reported two 
different growth trajectories in the domains of socialization and communication for high 
functioning and lower functioning children. High functioning children tended to have better 
expressive language and less severe autistic symptoms during childhood. In a more recent study 
using 50,000 nights of care-giver sleep/wake logs collected from 106 children with low functioning 
autism, aged 5 to 18 years old, Cohen et al. (2017) also identified two distinct sleep phenotypes 
with characteristics differences in the severity of key sleep features – total sleep time, sleep 
efficiency, frequency of night waking, and sleep onset. The group with highly variable and unstable 
Page 52 of 167  
sleep had significantly reduced full-scale IQ scores, communication scores, daily living, and overall 
adaptive behaviour composite scores, as measured by the VABS. No significant differences 
between the two distinct sleep phenotype groups in terms of age, gender, psychiatric comorbidities, 
medical comorbidities and use of medications that could affect sleep. The identification of these 
distinctive sleep profiles with robust association with adaptive functioning in children with low 
functioning autism would enable more individualized and effective therapies to be formulated and 
implemented. However, adaptive behaviour skills at baseline were seldom examined as predictors 
of treatment outcome; instead adaptive behaviour skills were often examined post-treatment and 
included as outcome measures (Perry et al., 2011). Studies consistently reported that pre-treatment 
higher adaptive behaviour skills, as measured using the VABS, were associated with positive 
response to treatment across various EIBI models (Flanagan et al., 2012; Perry et al., 2011; 
Remington et al., 2007; Sallows & Graupner, 2005). Furthermore, initial adaptive behaviour skills 
predicted better performance in children receiving treatments other than EIBI (Eaves & Ho, 2004; 
Eikeseth et al., 2007; Flanagan et al., 2015; Kim, Macari, Koller, & Chawarska, 2016; Magiati, 
Moss, Charman, & Howlin, 2011).  
IQ and Cognitive ability at baseline and treatment responses. It had been established 
that lower-functioning individuals have more severe symptoms and poorer coping skills and 
therefore exhibit more sleep problems than higher-functioning individuals (Hollway et al., 2013). 
Also, a relationship between sleep, maturational cognitive processes and adaptive skills has been 
established (Dan & Boyd, 2006). Hence, level of intellectual functioning (i.e. IQ and cognitive 
ability) at baseline would likely to provide some indications regarding the severity of sleep 
problems and, consequently, the level of sleep treatment responses. In children with ASD, Hollway 
et al. (2013) reported a positive association between IQ and Sleep Anxiety scores on the CSHQ, 
although IQ did not predict other sleep outcomes such as CSHQ Sleep Duration, CSHQ Bedtime 
Resistance, and CSHQ 23-item Total Scores.   
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The impact of cognitive ability on treatment outcome has been examined in several studies 
(Ben-Itzchak & Zachor, 2007; 2011; Ben-Itzchak, Watson, & Zachor, 2014; Eaves & Ho, 2004; 
Eldevik, Hastings, Jahr, & Hughes, 2012; Hayward, Eikeseth, Gale, & Morgan, 2009; Thurm, Lord, 
Lee, & Newschaffer, 2007; Turner & Stone, 2007) and is widely reported as a predictor of response 
to behavioural treatment in children with ASD. (i.e., higher cognitive ability at baseline is a strong 
predictor of improvements in cognitive ability, adaptive behaviour, language skills and ASD 
diagnostic classification following treatment) (Ben-Itzchak et al., 2014; Bibby, Eikeseth, Martin, 
Mudford, & Reeves, 2002; Eikeseth, Smith, Jahr, & Eldevik, 2002; 2007; Eldevik, Eikeseth, Jahr, 
& Smith, 2006; Hayward et al., 2009; Lovaas, 1987; Smith, Groen, & Wynn, 2000; Turner & Stone, 
2007; Zachor, Ben-Itzchak, Rabinovich, & Lahat, 2007). Similarly, low IQ and absence of language 
at 36 months predicted limited progress (Sallows and Graupner, 2005).    
Scope and severity of autism symptoms and treatment responses. Severity of autism 
symptoms can be defined based on the diagnosis of autism subtypes or levels of autism severity 
(Matson & Smith, 2008; Remington et al., 2007; Sallows & Graupner, 2005). However, a variety of 
measures of autism severity was used in past studies on children with ASD making comparison 
difficult (Howlin, Magiati, & Charman, 2009). Assuming more severe symptoms of ASD would 
result in poorer outcome is a logical first step in investigating the role that severity of autism 
symptoms has on treatment response. However, severity of autism symptoms has rarely been 
included as a potential predictor of outcome (Matson & Smith, 2008). Research findings were 
mixed. Some studies showed milder or lower baseline autism scores were predictive of better 
treatment responses (Eaves & Ho, 2004; Sallows & Graupner, 2005). In a 4-year longitudinal study 
of twenty-four children, aged 2 years 9 months to 2 years 10 months, with ASD receiving early 
intensive behavioural treatment, Sallows & Graupner (2005) reported that lower baseline autism 
scores, as measured by Autism Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & LeCouteur, 
1994) scores (together with higher IQ and more rapid early skill mastery) were predictive of rapid 
treatment responses. Based on a sample of forty-nine 2 year olds with social and language 
Page 54 of 167  
characteristics suggestive of autism, Eaves and Ho (2004) also reported that higher functioning 
children with milder autism, based on the Childhood Autism Rating scale (Schopler, Reichler, & 
Renner, 1988), were the most improved. In a separate study of predictors of treatment outcomes for 
children, aged 1 year 10 months to 4 years 10 months, with ASD receiving Early Start Denver 
Model (ESDM; Rogers & Dawson, 2010) in a group setting, Vivanti et al. (2013) reported that less 
severe autism symptoms at baseline, as measured by Autism Diagnostic Observation Schedule 
severity score (ADOS; Lord, Rutter, DiLavore, & Risi, 1999), appeared to play a role in predicting 
treatment gains in both expressive and receptive language. Ben-Itzchak & Zachor (2007) conducted 
a study of 25 children, aged 1 year 8 months to 2 years 8 months, with ASD. The study focused on 
severity of autism symptoms in the area of language and communication and reciprocal-social 
interaction, as measured by the ADOS. Using median scores in the language and communication 
section, children were divided into high and low communication groups. Similarly, using median 
scores in the reciprocal-social interaction section, children were divided into high and low social 
groups. Children with higher initial cognitive levels and fewer early social interaction deficits 
showed better acquisition of receptive language, expressive language, and play skills, although, 
severity of the measured communication deficits was not related to outcome in any developmental 
domain. In a more recent study with a very large and diverse sample of children (n = 332), aged 
approximately 2- to 7-years-old, Perry et al. (2011) reported that children with milder or fewer 
autism symptoms at intake, as measured by the Childhood Autism Rating (CARS; Schopler, 
Reichler, & Renner, 1988) scale, were more likely to achieve positive responses to treatment. In 
contrast, a randomized control trial was conducted with two groups of pre-schoolers, aged between 
21/2 years and 31/2 years, with ASD. There were twenty-three pre-schoolers in the treatment group 
and twenty-one pre-schoolers in the comparison group. Assessments were taken prior to 
intervention, after 1 year and after 2 years of intervention. More autistic symptoms of autism at 
baseline, as reported on the Developmental Behaviour Checklist - Autism Screening Algorithm 
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(Einfeld & Tonge, 2002) by both parents, were associated with more positive responses to treatment 
(Remington et al., 2007).  
Gender differences and treatment responses. The presentation of ASD clinical symptoms 
are different between male and female (Lai, Lombardo, Auyeung, Chakrabarti, & Baron-Cohen, 
2015) and seemed to be influenced by age. Studies of children, aged 1 year 4 months to 3 years 10 
months, concluded that there were no major sex differences in ASD manifestation. However, sleep 
problems and anxious or depressed affect were more prevalent in girls (Hartley & Sikora, 2009; 
Reinhardt, Wetherby, Schatschneider, & Lord, 2015). In contrast, studies of older children and 
adolescents with ASD, aged 3 to 18 years, found gender differences in restricted interests, 
hyperactivity, and social anxiety. Higher hyperactivity levels were common in males and social 
anxiety were more prevalent in females (May, Cornish, & Rinehart, 2014). Females with ASD who 
were cognitively abled had substantially lower levels of restricted interests and those with lower 
cognitive ability had greater social communication impairment, weaker adaptive skills and greater 
externalizing problems relative to males (Frazier, Georgiades, Bishop, & Hardan, 2014; Frazier & 
Hardan, 2017; Mandy et al., 2012). However, gender is rarely considered when making diagnostic 
or treatment decisions (Pinares-Garcia, Stratikopoulos, Zagato, Loke, & Lee, 2018). Hence, major 
advancements in the prevention or treatment of ASD in both males and females can be achieved by 
a better understanding of the gender difference (Halladay et al., 2015). In a recent study of thirty-
five 3-year-old children with ASD, Tiura et al. (2017) included gender in the study to control for 
any gender differences that might arise in parent reported outcome measures. Results showed that 
male participants tended to improve more quickly in the areas of adaptive behaviour and physical 
development; however, the authors noted that the small sample of female participants might have 
resulted in limited variability, thus affecting the result. In contrast, in a longitudinal study of 
patterns of growth in verbal abilities among 2-year-old children with ASD assessed at age 3, 5 and 
then 9 years old, Anderson et al. (2007) found that gender was not predictive of treatment 
outcomes.  
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Externalising/Internalising behaviour problems at baseline and treatment responses. In 
typically developing children, sleep problems are associated with behavioural difficulties. However, 
the directionality of this association is unclear. Furthermore, the question of whether different 
behavioural difficulties are associated with different type of sleep problems remains to be answered. 
Understanding of these associations will undoubtedly improve treatment responses (Quach, 
Nguyen, Williams, & Sciberras, 2018). In a longitudinal study of 4983 typically developing 
children aged 4 to 5 years old, Quach et al. (2018) reported that interventions targeting 
externalising, but not internalising, difficulties might improve childhood sleep and further research 
were necessary to investigate whether sleep problem interventions decreased the occurrence of both 
externalising and internalising difficulties. Sleep problems are also associated with behavioural 
difficulties in children with ASD (Goldman et al., 2009; 2011; Malow et al., 2006a; Mayes & 
Calhoun, 2009). In a longitudinal study of 437 children, aged 2 to 10 years, with ASD assessed at 
baseline and follow-up 3.8 years later, sleep problems at baseline predicted somatic complaints in 
older children. Negative longitudinal effects of sleep disturbance were found on attention and 
hyperactivity in children with ASD. However, no significant predictive relationship was found 
between sleep problems and anxiety. Nevertheless, treating sleep problems might have a positive 
impact on attention and behavioural regulation and future research is needed to determine whether 
treatment of sleep problems prevents or reduces inattention and hyperactivity in early childhood for 
children with ASD (Mazurek, Dovgan, Neumeyer, & Malow, 2019).  
Studies on the association between problem behaviours and responses to early intensive 
behavioural intervention could provide some insights relevant to the study of problem behaviours 
and responses to treatment for sleep disturbances. In a two-year longitudinal study of early intensive 
behavioural intervention for children with ASD, Remington et al. (2007) reported that more 
problem behaviours, as measured by the Developmental Behaviour Checklist (DBC; Einfeld & 
Tonge, 2002), were associated with more positive responses to treatment. There was, however, no 
reduction in parental reports of children’s behaviour problems, following early intensive 
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behavioural intervention, which came as a surprise to the authors and was attributed to the absence 
of detailed functional analysis and function-informed interventions for problem behaviours were not 
the prominent components. Nevertheless, positive benefits of behavioural intervention had been 
expected given the known association between behaviour problems and severity of cognitive and 
adaptive functioning, especially in language or communication skills (Remington, et al., 2007). In 
another study, Henderson et al. (2016) reported that, in comparison to non-autism group (n = 57), 
parents of children with ASD (n = 58) reported higher rates of externalising behaviours and 
significantly less frequent general routine (i.e., daily living routines, household responsibilities, 
homework routine, and discipline routine). No interaction was found between diagnostic group and 
consistency of bedtime routines in predicting externalising behaviour problem and the authors 
reasoned that externalising behaviours might be influenced by multiple factors in addition to 
bedtime routines (Henderson, Barry, Bader, & Jordan, 2011).  
In one of the first studies to explore observational relations between sleep and behaviour in 
the context of intensive behavioural intervention, Abel et al. (2018) conducted a study using a 
sample of 39 children, aged 2 to 10 years, with ASD receiving intensive behavioural intervention. 
Results showed no significant day-night associations between children’s sleep and challenging 
behaviours. Instead, average patterns of sleep over time appeared to be more influential in 
challenging behaviours than daily fluctuations in sleep. Despite receiving intensive behavioural 
intervention, children who slept less (on average) exhibited significantly higher rates of repetitive 
behaviour. Also, children who had more night wakings (on average) during the week engaged in 
higher rates of negative affect (Abel, Schwichtenberg, Brodhead, & Christ, 2018).   
 Co-morbidity and treatment responses. Additional psychopathology or conditions were 
likely to exacerbate problems associated with treatment effectiveness (Matson & Smith, 2008). 
Studies pointed to the associations of co-occurring presence of psychological symptoms and 
treatment responses. For example, in a study of 152 students with ASD after one year of school-
based behavioural intervention (discrete trial training, pivotal response training, and teaching within 
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functional routines), Pellecchia et al. (2016) examined associations between treatment outcome, as 
measured by changes in cognitive ability, and child characteristics (including age, social skills, 
adaptive behaviour, autism severity, autism core symptoms, language ability, and co-occurring 
presence of psychological symptoms). The study found that age and co-occurring presence of 
psychological symptoms, specifically the presence of symptoms associated with social anxiety, 
were associated with differences in treatment outcome. Although the study recommended that 
further examination on the presence of symptoms associated with social anxiety to identify the 
individual component of the construct of social anxiety (either social fearfulness or social 
motivation) and to include treatments for addressing the particular component of social anxiety, the 
important implication presented by the Pellecchia et al. (2016) study was that, given the association 
between increased social anxiety symptoms and poorer treatment outcomes, addressing the co-
occurring presence of psychological symptoms early might have a profound impact in maximising 
treatment outcomes.  
 Medications and treatment responses. Children with ASD are often prescribed 
medications to treat autism symptoms or comorbid psychopathology, including depressions, 
ADHD, irritability and so on; however, some of these medications might have effects on sleep and, 
hence, might improve or worsen sleep problems. For example, antidepressants with sedative 
properties (e.g., Mirtazapine, Doxepin, Trazodone) rapidly improve sleep, but might cause 
problems in long-term treatment due to over-sedation. Others with activating effects (e.g., 
Venlafaxine, Fluoxetine) might disrupt sleep at least in short-term treatment. In addition, some 
antidepressants might also worsen or induce sleep disorders like sleep bruxism, restless leg 
syndrome, rapid eye movement sleep behaviour disorder, sleep apnoea, and nightmares (Wichniak, 
Wierzbicka, Walecka, & Jernajczyk, 2017). Studies have also shown that children with ASD 
prescribed with psychostimulant medications (Methylphenidate and Atomoxetine) considered to be 
effective to treat ADHD-like symptoms in autism (Clemow, Bushe, Mancini, Ossipov, & 
Upadhyaya, 2017; Cortese, Castelnau, Morcillo, Roux, & Bonnet-Brilhault, 2012) reported adverse 
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effects of irritability, insomnia and emotional outbursts associated with taking Methylphenidate 
(Posey et al., 2007; Simonoff et al., 2013); and fatigue, early morning waking, and initial insomnia 
due to Atomoxetine (Harfterkamp et al., 2012). Similarly, in large controlled psychopharmacology 
trials in children with autism administered with Risperidone or Aripiprazole (medications for 
treatment of irritability associated with ASD), common adverse effects reported were fatigue, 
sedation and drowsiness (Marcus et al., 2009; McCracken et al., 2002). Clearly, any medications 
that had effects on sleep might influence the implementation, efficacy and success of behavioural 
based interventions.  
In summary, for initial age, adaptive skills, severity of autism, gender, and externalising or 
internalising behaviours, results are not completely consistent and further research is needed 
(Henderson et al., 2011; Mazurek et al., 2019; Pellecchia et al., 2016; Perry et al., 2011; Remington, 
et al., 2007; Tiura et al., 2017). In contrast, higher IQ and cognitive ability has more consistently 
predicted treatment responses (Ben-Itzchak, Watson, & Zachor, 2014; Fossum et al., 2018; Howlin 
et al., 2009; Reichow, 2012) and medications prescribed to children with ASD might have effects 
on their sleep (Harfterkamp et al., 2012; Marcus et al., 2009; McCracken et al., 2002; Posey et al., 
2007; Simonoff et al., 2013; Wichniak et al., 2017). 
Limitations of Existing Research 
Overall, knowledge of child characteristics that were associated with differences in 
treatment responses is limited (Sherer & Schreibman, 2005). The majority of previous studies had 
investigated child characteristics that were predictive of treatment responses in intensive behaviour 
intervention and very limited studies were conducted to investigate child characteristics as a 
predictor of response to treatment of sleep disturbance. Nevertheless, relying on existing research 
on intensive behaviour intervention to inform the choice of individual-specific factors to investigate 
in the present study seemed to be a reasonable starting point.  
Unfortunately, many of the previous studies that have investigated the relationship between 
case complexity and treatment responses are subject to a number of limitations.   
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First, in most cases, intervention type, intensity and duration might have varied resulting in 
non-standardized and individualized interventions employed in the sample potentially confounding 
the observed findings and preventing analysis of which factors contributed to the outcomes (Knight 
& Johnson, 2014; McLay, France, Knight, Blampied, & Hastie, 2019; Pellecchia et al., 2015).   
Second, limited numbers of participants were identified for specific behavioural 
interventions. Single-case study design was often used and no control group was included in the 
majority of the studies. Although as an important first step to begin testing an intervention, not 
including a control group was acceptable since the use of baseline period allowed for comparison of 
behaviour before and during treatments and any improvement observed during the intervention 
period relative to baseline could be viewed as a benefit of the intervention (Smith et al., 2007). 
However, the limited number of participants in many of the studies causing the studies to be 
underpowered to study predictors of outcome (Pellecchia et al., 2015). 
Third, child characteristics (i.e., cognitive ability, autism symptom severity, adaptive 
behaviours, language skills) investigated as predictors of treatment outcome were not directly 
modifiable because these constructs reflect a variety of distinct underlying processes, making it 
difficult to understand the specific mechanisms underlying treatment response (Fossum et al., 2018; 
Vivanti, Prior, Williams, and Dissanayake, 2014).     
Fourth, previous studies did not account for the presence of co-occurring psychological 
symptoms or concurrent medications, and their potential effects on the responses to treatments in 
children with autism (Masi et al., 2017; Pellecchia et al., 2016).   
Fifth, reported findings might not be generalized to the larger population of children with 
ASD because sample used in the study was children referred to outpatient or university-based 
clinics rather than children selected from community-based settings (Pellecchia et al., 2016).  
Sixth, the role of co-variates such as age, socio-economic status, and family factors were not 
evaluated to determine the impact of these factors had on the responses to behavioural sleep 
interventions (Rigney et al., 2018).   
Page 61 of 167  
Seventh, limited randomized controlled trials were performed. Well-powered clinical trials 
would enable estimation of potential benefits of a specific intervention and exploration of additional 
factors, such as identification of specific individuals who would benefit most from the intervention 
and the reasons behind such benefits (Vivanti et al., 2018). A randomized controlled trial would 
determine the effectiveness of the intervention and strengthen external validity of the findings 
(Sanberg, Kuhn, & Kennedy, 2018).     
Rationale 
This review has demonstrated the relationship between sleep problems and children’s autism 
symptoms and severity (e.g., social interactions and communication difficulties, stereotyped and 
repetitive behaviour), adaptive behaviour, challenging behaviour (externalising and internalising), 
comorbid symptoms (e.g., hyperactivity and inattention). In addition, the relationship between case 
complexity (e.g., biological, psychological, behavioural, prescribed medications) and treatment 
responses has been explored. The child characteristics that were predictive of treatment responses in 
other behavioural interventions served to inform the choice of individual-specific factors to 
investigate in the present study.  
Hence, the present study adds to the literature by examining the extent to which biological, 
developmental, and psychopathological characteristics predicted treatment outcome for sleep 
problems in children with ASD. By focusing only on individuals with an ASD diagnosis and not 
comparing with typically developing individuals, the understanding of any individual and subgroup 
differences within the autism spectrum, and how these differences affected treatment responses 
would allow for individual customisation of treatment programmes and for improving the 
effectiveness of such programmes (Georgiades, Szatmari, & Boyle, 2013). Furthermore, by 
identifying these differences and understanding the impact that these differences have on treatment 
responses, there will be opportunities to individually tailor and increase the effectiveness of 
treatment programmes (Eapen et al., 2013). Specifically, this study investigates the following 
research questions:  
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(1) Did the treatment alter the child’s sleep to a clinically significant degree?  
(2) Is there a latent complexity variable affecting the child’s responses to treatment?  
(3) Do the latent complexity variable and any children’s characteristics (i.e., gender, age, 
autism core symptoms severity, co-morbid psychopathology, sleep problems severity, behaviour 
severity, and medications) serve as predictors of treatment responses?  
By answering these research questions, efforts will be made to identify critical factors so 
that these factors can be addressed early to maximise treatment outcomes. 
  





This thesis involved the examination and analysis of pre- and post-treatment psychometric 
assessment data collected from a subset of children with ASD who were enrolled in a larger study 
evaluating the effect of behavioural interventions for sleep problems. This chapter describes the 
current project within the context of the wider sleep and autism research study being undertaken by 
a team of researchers at the University of Canterbury.  
The present study in the context of the larger sleep and autism study 
The larger study focused on investigating the effectiveness of behavioural interventions for 
sleep problems in children with ASD. In this study, individualised interventions were formulated 
based on the outcome of Functional Behaviour Assessment (FBA). The effect of these interventions 
was then evaluated.  The focus of the present study was to examine the relationship between child 
complexity variables and treatment response in children with ASD who participated in this larger 
study. A post hoc analysis of variables was conducted in order to identify predictors of treatment 
responses.  
The Sleep Research Team 
The Sleep Research Team at the University of Canterbury is comprised of two senior 
academics, registered intern psychologists, PhD and Masters thesis students.    
Ethics and Participant Consent 
 Ethical approval was obtained from the University of Canterbury Human Ethics Committee 
as a part of the larger Sleep and Autism Study (HEC #2014/150). This study drew upon archived 
data from the larger study and no additional approvals or consents were required. 
 All parents were required to provide consent for their child to participate in the Sleep and 
Autism study. An initial phone discussion was carried out with each family to ensure caregivers or 
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parents fully understood the nature of the study. Children were informed verbally regarding the 
study and its requirements. A copy of the information sheets and consent forms were then provided 
to children/young people and their parents (see Appendix A to D).  Before the start of the study, 
parents/caregivers and children provided informed consent or assent, respectively.  
Research Design 
For the larger Sleep and Autism study, a non-concurrent single-case multiple baseline across 
participants design was used to examine the effects of function-based behavioural interventions. As 
each case was unique, the corresponding treatment plan was individualised. Use of a single case 
research design allowed for close monitoring of the intervention effects and opportunities to refine 
the intervention techniques. Single case research design is also a useful starting point for 
establishing efficacy because such designs provide evidence that the intervention technique has a 
clear and replicable effect on a specific behaviour (Smith et al., 2007).    
Study Phases in the larger Sleep and Autism study 
The Sleep and Autism study consisted of the following phases.  
Assessment. All questionnaires analysed in the present study were administered as part of 
assessment conducted during the larger Sleep and Autism study. In addition to the administering the 
measures, FBA was conducted. Information gathered was used for treatment formulation, planning, 
and measuring changes following intervention. During the assessment phase, parents were advised 
to respond in the usual manner and not making any changes to the child’s sleep patterns.     
Clinical interview. During the assessment phase of the larger Sleep and Autism study, an 
open-ended clinical interview was conducted by a registered psychologist or a registered intern 
psychologist who was under supervision of a clinical psychologist. To guide the functional analysis 
of the child’s sleep problems, the Sleep Assessment Treatment Tool (SATT; Jin et al., 2013) was 
used. The SATT includes questions that investigate and identify (1) the history of a child’s sleep 
problems; (2) the parent or caregivers goals for intervention; (3) the nature and severity of the 
presenting sleep problems (bedtime routine issues, delayed sleep onset, sleep interfering behaviour, 
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night wakings, early morning wakings); (4) antecedent and consequence variables that precipitate or 
maintain the sleep problem; (5) the current pre-sleep routine and sleep schedule; (6) the child’s 
sleep setting; (7) any sleep dependencies (i.e., events lead to bedtime, items needed during 
bedtime); and (8) any sleep interfering behaviour. During the interview, information was also 
sought in regard to (1) any previous attempts to address the sleep problem; (2) possible risk factors 
(i.e., parental psychopathology, drugs or alcohol issues, marital discord); (3) past or present medical 
or physical conditions that may have an impact on the child’s sleep (i.e., comorbid 
psychopathology, asthma, obstructive sleep apnoea).  
Baseline. Each participant was randomly assigned a baseline length of one, two, or three 
weeks.  During the baseline phase, parents were advised not to modify their responses to the child’s 
behaviour and not change the sleep routine. Parents would collect sleep diary data and video 
recordings.  Both the information obtained from clinical interview and sleep data obtained during 
the baseline phase was used to inform the intervention plan.    
Intervention. Intervention commenced immediately upon conclusion of baseline. Parents 
continued to record sleep diary data and video recordings throughout the intervention phase. Sleep 
interventions for children were individualized based on the outcome of the FBA, and typically 
consisted of antecedent and consequence-based modifications (e.g., modifications to sleep hygiene 
and bedtime routines, modification to sleep/wake schedules, use of visual supports (e.g., Gro 
Clocks), social stories, stimulus substitutions, faded parental presence, extinction, and 
reinforcement procedures.  
In each case, the goal of treatment was to promote sleep-conducive behaviour and to 
eliminate sleep interfering behaviours. and the treatment plan was developed in collaboration with 
the parents (i.e., it integrated their goals and preferences). Parents or caregivers maintained regular 
contact with researcher throughout treatment via the phone, email or SMS text. Regular contact was 
maintained to provide motivation, increase parents’ confidence in implementing the treatment plan, 
and resolve issues with expediency. Treatment was maintained until notable progress had been 
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made, as agreed with the parents or caregivers, until the sleep problem had been resolved, or until 
the parents chose to withdraw from the study.   
Maintenance. The maintenance phase commenced immediately on completion of treatment.  
During this phase the researcher did not initiate any contact with the child’s parents. During this 
phase, parents and children would have the opportunity to maintain the newly acquired behaviours 
in their daily lives (Blampied, 2013). At the conclusion of this phase, a semi-structured interview 
was conducted with parents or caregivers to gain feedback on their level of satisfaction with the 
treatment outcomes and post-treatment questionnaires were administered.  
Follow-up. Short- and long-term follow-up data was collected 4-6 and 10-12 weeks post-
treatment respectively. During this phase, parents or caregivers collected one week of sleep diary 
data and video recordings. The purpose of the follow-up phase was to assess the maintenance of 
treatment effects over time.   
Present study 
For the present study, a retrospective pretest-posttest research design was used to investigate 
the predictors of response to function-based interventions to treat sleep problems among children 
with a diagnosis of ASD. Cases were drawn from those who completed treatment and provided 
information for at least one, follow-up phase. Random assignment to treatment and control groups 
were difficult to carry out for practical and/or ethical reasons. All children in the larger Sleep and 
Autism study were referred to the study due to the seriousness of their sleep disturbances. Hence, it 
was not possible to randomly assign children to the treatment program or to no treatment program. 
Two important steps were taken to determine that it was the treatment that brought about change for 
each child. First, a multiple-baseline was used in the larger Sleep and Autism study to confirm a 
replicated pattern of change from baseline to intervention supported by relatively little delay 
between implementation of treatment and change (Barlow, Nock, & Hersen, 2009). Second, a large 
clinically significant treatment effect should be observed in the SPS scores at either short- or long-
term follow-up, as evidence that the combination of non-specific (Barker, Pistrang, & Elliot, 2013) 
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and specific treatment effects had been highly positive for these children and their families (McLay 
et al., 2019).  
Participants in the larger Sleep and Autism study 
Recruitment. For the larger study, participants were recruited from organizations 
throughout New Zealand that provide services to children with ASD, via the networks of the 
research team, or through self-referral.   
 Inclusion/exclusion criteria. Participants were enrolled in the larger study if they met the 
following inclusion criteria: (1) aged between 3 and 18 years of age; (2) had a formal diagnosis of 
ASD made by a paediatrician, registered psychologist or psychiatrist; (3) had parent-reported sleep 
issues including, but not limited to, delayed sleep onset (time taken to fall asleep), frequent and 
prolonged night wakings, early morning awakenings, and/or co-sleeping. Children with a medical 
condition that may affect their ability to follow the study procedures were excluded from the study. 
Data from participants in the Sleep and Autism study who completed the treatment phase was 
examined and analysed.    
Recruitment for the present study. Participants were 31 (of 42) children who had 
participated in the Sleep and Autism study who also met criteria for the current study.   
 Participants in the present study. Data were obtained from 6 girls and 25 boys between 3 
and 14 years of age.  All children had a formal diagnosis of ASD. Rather than drawing a 
comparison with typically developing children, the present study aimed to understand the meaning 
of individual and subgroup differences on treatment outcomes within the children with a diagnosis 
of ASD. A summary of participant characteristics is presented in Table 1.  
Measures 
Sleep measures.  
The following measures were used in present study and the larger Sleep and Autism study. 
Information collected from sleep diary and video recordings were used to calculate sleep problem 
severity scores.  
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Table 1 
Summary of Participant Characteristics 
Characteristics      Values (percentages) 
Total number of participants      31  
Age range        3-14 years old 
Mean Age        6 years and 8 months 
Male        25 (81%) 
Participants with more than one diagnosis   8 (26%) 
Night Wakings      10 (32%) 
Co-sleeping       9 (29%) 
Sleep Onset Delay (SOD)     7 (23%) 
Early Morning Waking     3 (10%) 
Parental Presence during SO     8 (26%) 
Bedtime Resistance      2 (7%) 
Multiple parent-reported sleep problems   10 (32%) 
 
 Sleep diary. Sleep diaries were used by parents or caregivers to record daily sleep data. The 
data included (1) daytime sleep (setting, time asleep, time awake), (2) setting of night time sleep, 
(3) time put to bed, (4) frequency of curtain calls (i.e. child’s bids for parental attention after the 
child was put to bed), (5) description of the curtain calls, (6) parent’s responses to child’s curtain 
calls, (7) estimated time of initial sleep onset, (8) time, frequency and duration of night wakings as 
well as a description of child’s behaviour during night wakings and parents or caregiver responses 
to the behaviours, and (9) morning wake-up time.  Information obtained from the sleep diary was 
used to determine bedtime at night, wake up time, number of nights spent co-sleeping, parental 
presence during sleep onset and following night waking. The information was then used to calculate 
sleep onset latency in minutes (i.e., the difference between bedtime and time till silence), duration 
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of night wakings in minutes, frequency of night wakings, duration of early morning wakings, and 
total sleep time (i.e., the difference between time till silence and wake-up time). Sleep diaries were 
recorded by parents or caregivers for a minimum of two weeks during the assessment phase, and 
then every night during the baseline, intervention, and follow-up phases of the study. A copy of 
standard template used for sleep diary is included in Appendix E.  
 Sleep diaries were collected at least once a week during the assessment phase in order to 
ensure the diaries were completed accurately, to inform the development of the treatment, and to 
confirm the eligibility for the study. Sleep diaries were also collected at least once per week during 
the baseline phase. However, during intervention phase, daily contacts were made with the families 
to collect sleep diaries in order to inform and to allow for prompt changes to the intervention 
strategies if necessary. During follow-up, sleep diaries were collected at the end of follow-up period 
which typically ran for a week.  
Video recordings. Night-time infra-red video recordings were used to capture child 
behaviours after they were put to bed. The video equipment contained adequate storage capacity to 
record for the duration of the night. Video recordings were collected for a minimum of 30% of 
baseline, intervention and follow-up phases of the study. In the present study, video recordings were 
used to supplement data from sleep diaries and used, as part of the FBA process, to analyse 
antecedent and consequence variables that might be maintaining the sleep problems.  
Inter-Observer Agreement (IOA). In order to obtain IOA, information recorded in the sleep 
diaries were compared with the video recordings. This task was performed by a research assistant 
who was blind to the sleep diaries. At least 20% of the video recordings were viewed by the 
research assistant across each phase of the study and information was recorded on a separate sleep 
diary similar in format to the sleep diary completed by the family. In terms of frequency and 
occurrence of the behaviour, agreement was recorded if both the parent and the observer observed 
the occurrence and frequency of the behaviour. Disagreement was recorded if only one party 
observed the behaviour. In terms of duration of observed behaviours, agreement was recorded if 
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both parent and observer’s recorded duration were within 15 minutes of each other. A percentage of 
agreement for each behaviour was then calculated using the equation [Agreements/(Agreements + 
Disagreements)] x 100.   
The Children’s Sleep Habits Questionnaire (CSHQ; Owens, Spirito, & McGuinn, 2000). 
The CSHQ was administered during baseline and post-treatment phase. The CSHQ is a 33-item 
rating scale designed to assess the type and severity of sleep problems in children aged 4-10 years. 
It contains items related to eight sleep subscales: (1) Bedtime Resistance, (2) Sleep Onset Delay, (3) 
Sleep Duration, (4) Sleep Anxiety, (5) Night Wakings, (6) Parasomnias, (7) Sleep Disordered 
Breathing, and (8) Daytime Sleepiness. Parents or caregivers report the frequency of particular 
sleep behaviours observed over the previous week on a three point scale: Rarely (0-1 night per 
week), sometimes (2-4 nights per week), or usually (5-7 nights per week). In addition, parents or 
caregivers are requested to indicate whether these particular behaviours are a problem for the 
family. A total sleep disturbance score is then calculated together with the eight subscale scores 
relating to specific sleep disturbances. 
Owens and colleagues (2000) reported an internal consistency of 0.68 and 0.78 for the 
community sample (n = 469) and clinical sample (n = 154), respectively. Test-retest reliability was 
acceptable (range 0.62 to 0.79). Receiver operator characteristic (ROC) analysis identified a total 
score of 41 as the clinical cut-off for sleep problems with a sensitivity of 0.80 and specificity of 
0.72. (Owens et al., 2000). Goodlin-Jones and colleagues (2008) showed that the CSHQ 
discriminated between good and poor sleepers in a sample of 194 preschool children, typically 
developing and those with ASD, down to 2 years of age (Goodlin-Jones et al., 2008).  
For the purpose of the present analysis, CSHQ total raw scores were used as a measure of 
dimensions for child clinical complexity and used to identify latent factors predicting the responses 
to treatment.  Higher CSHQ scores indicate higher parent-reported sleep problems.   
Measures of Sleep Problem Severity. Following McLay, France, Knight, Blampied and 
Hastie (2019), a measure of Sleep Problem Severity (SPS) was formulated using an adapted version 
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of the Sleep Behaviour Scale (SBS; Richman, 1985). The SPS scoring system was adapted to 
incorporate developmental norms regarding bedtimes and total sleep time from the National Sleep 
Foundation Guidelines (NSF; Hirshkowitz et al., 2015; Ohayon et al., 2017) and include percentage 
of night spent co-sleeping each night and parental presence for initial sleep onset and parental 
presence during sleep onset following night waking. The percentage of night spent co-sleeping each 
night has five categories (0, 1, 2, 3, 4), where 0 was considered to be developmentally appropriate 
and 4 was considered to contributing to significant sleep problems.  Parental presence for initial 
sleep onset or parental presence during sleep onset following night waking was dichotomy (0, 1), 
where 0 was considered to be developmentally appropriate and 1 was considered to be contributing 
to sleep problems. The items on parental presence are added to reflect the strong negative 
association between total sleep time and parental presence for initial sleep onset as well as the 
association between parental presence and increased night wakings. Items from the original SBS 
included average time taken to sleep or average bedtime (whichever is worse), average total time 
slept at night, average numbers of night waking per week, average number of wakings per night, 
average time awake per waking, and average weekly hours in parents’ bed. Each item has five 
categories (0, 1, 2, 3, 4), where 0 was considered to be developmentally appropriate and 4 was 
considered to be having significant sleep problems.  
The SPS Scoring system was adapted for three different age groups, to reflect 
developmental norms: preschool-aged children (aged 3 to 4 years and 11 months old), primary 
school-aged children (aged 5 to 12 years old) and teens (aged 13 years old and above). Detailed 
developmentally-appropriate items for SPS score calculation for pre-school, primary school-aged, 
and adolescents are attached in Appendix F to H. SPS scores were calculated for the final seven 
days of baseline and treatment, and all seven days of short- and long-term follow-up (where 
available).  Average of the seven daily SPS score (daily score summed over 7 days and then divided 
by 7) was considered as the SPS score for each week. The clinical direction of change for SPS 
scores is to reduce if sleep improves after completion of treatment. Data for the SPS score was 
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predominantly obtained from sleep diaries though on occasion, it was necessary to supplement this 
with video recordings (e.g., if insufficient data was recorded in the sleep diary).  
Measures of children’s daytime functioning and behaviour.  
The following measures were administered in the larger Sleep and Autism study and the 
data obtained were examined and analysed in the present study to inform child-specific dimensions 
of clinical complexity. 
Child Behaviour Checklist (1.5-5 years, 6-18 years) (CBCL; Achenbach & Rescorla, 
2001). The total CBCL scores are used to provide an assessment of the severity of dysfunction 
across a broad range of symptom domains and has been used frequently in assessment and 
intervention studies (Kazdin & Whitley, 2006). The CBCL was used to assess child 
psychopathology, social competence, and daytime behaviour. The CBCL is a questionnaire 
completed by parents or caregivers based on their knowledge and observations of their child’s 
daytime behaviour. The CBCL examines psychopathology and daytime behaviour across eight 
domains (anxious/depressed, somatic complaints, withdrawn/depressed, aggressive behaviour, rule-
breaking behaviour, thought problems, social problems, and attention problems) and is used to 
calculate sub-domain scores (Internalizing, Externalizing, and other syndrome scales). There are 
two versions of the CBCL: preschool (age 1.5 to 5 years old) and school age (aged 6 to 18 years 
old). Mean test-retest reliabilities of r = .85 and r = .88 across eight day period for the preschool 
and school age forms, respectively (Achenbach & Rescorla, 2001). The CBCL T-score was used as 
a measure of ASD symptom severity. By definition, T-scores of less than <65 (<93rd percentile) are 
in the normal range, between 65 and 70 (93rd-98th percentile) are in the borderline clinical range, 
and ≥70 (≥98th percentile) are in the clinical range (Bruni et al., 2007; Goldman et al., 2009). CBCL 
was administered during the baseline and maintenance phase of the larger Sleep and Autism study. 
In the present study, the CBCL T-score was considered as dimensions of child clinical complexity 
measures and used to identify latent factors predicting the responses to treatment.    
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The Gilliam Autism Rating Scale, Second Edition (GARS-2; Gilliam, 2006). The GARS-2 
was used to identify ASD and to evaluate the severity of autism symptomology based on the 
diagnostic criteria of the DSM-IV-TR. The GARS-2 is a norm-referenced 42-item, parent or 
caregiver report, screening questionnaire. It is appropriate for use with individuals between the ages 
thatof 3 and 22 years. The GARS-2 contains three subscales – Communication, Stereotyped 
Behaviours, and Social Interaction. Each item is rated on a four-point Likert scale (0 = “Never 
Observed”, 1 = “Seldom Observed”, 2 = “Sometimes Observed”, and 3 = “Frequently Observed”).  
Total raw scores on the 14-item subscales are converted to standard scores. Based on the total 
standard scores from the Stereotyped Behaviour and Social Interaction subscale, a norm-referenced 
total score, the Autism Index (AI; M =100, SD = 15) is calculated. The Autism Index is used to 
classify the risk for autism. AI scores ≤69 suggest that autism is “unlikely”. AI scores between 70 
and 84 suggest that autism is “possible”. AI scores ≥85 suggest that autism is “very likely”. 
Evidence of the reliability and validity of the GARS-2 indicates that internal consistency estimates 
were .86 for Communication, .84 for Stereotyped Behaviours, .88 for Social Interaction, and .94 for 
the Autism Index. Corrected test-retest coefficients (1-week interval) based on parent ratings of 37 
children with ASD were .70 for Communication, .90 for Stereotyped Behaviours, .88 for Social 
Interaction, and .88 for the overall Autism Index. Using a cut-off score of 85 for the GARS-2 
Autism Index, sensitivity and specificity for the ASD group versus typical controls were 1.00 and 
.87, respectively (Gilliam, 2006). The GARS-2 classification of autism risk was used as a measure 
of autism symptom severity. The autism severity level was coded as two when, based on GARS-2 
convention, autism was ‘possible’ and the autism severity level was coded as a three when autism 
was ‘very likely’. The GARS-2 was administered during baseline and maintenance phase of the 
larger Sleep and Autism study. In the present study, the GARS-2 Autism Index level was 
considered as dimensions of child clinical complexity measures and used to identify latent factors 
predicting the responses to treatment.    
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The Vineland Adaptive Behaviour Scales, Second Edition (VABS-II; Sparrow, Cicchetti, 
& Balla, 2005). The VABS-II is used to assess the adaptive behaviour of individuals from birth 
through to adulthood. For the Sleep and Autism study, only the VABS-II receptive and expressive 
communication sub-domains were administered. Items on the VABS-II are rated on a scale from 
zero to two with zero representing behaviour never performed, one representing behaviour 
sometimes or partially performed, and two representing behaviour usually or habitually performed. 
Domain scores and the composite scores are standardized (M = 100, SD = 15). Test-retest reliability 
for the VABS-II has been established; subdomain reliability coefficients are excellent with most 
values exceeding .85 (Sparrow et al., 2005). The VABS-II was used during the assessment phase in 
the larger Sleep and Autism study to determine the child’s level of receptive and expressive 
language, to confirm their eligibility for the study, and to tailor the interventions to the child’s level 
of understanding. In the present study, the VABS-II v-scale score was considered as dimensions of 
child clinical complexity measures and used to identify latent factors predicting the responses to 
treatment.   
Other measures.  
In the present study, types of comorbid psychopathology were consolidated into categorical 
variable of comorbidity. Types of medications were consolidated into categorical variable of 
medications.   
 Comorbidity. Comorbidity was calculated based upon the number of Diagnostic and 
Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association [APA], 
2013) diagnoses other than ASD. For example, Global Developmental Delay (GDD), Attention 
Deficit Hyperactivity Disorder (ADHD), Dissociative Disorders (DD), Tic Disorders, Specific 
Learning Disorder (SLD), Dyscalculia, and Developmental Coordination Disorder 
(DCD)/Dyspraxia. Due to the relatively small number of children having additional diagnosis, the 
variables were collapsed into the following categories (0, 1, 2, 3), where 0 was designated for ASD 
diagnosis only, 1 for ASD and other sleep comorbidities (i.e., delayed sleep onset latency, co-
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sleeping, frequent or prolonged night wakings, early morning wakings), 2 for ASD and non-sleep 
comorbidities, and 3 for both sleep and non-sleep comorbidities in addition to ASD. In the present 
study, the category of comorbidity was included as one of the measures used to identify latent 
variables that would serve as a dimension of child clinical complexity.    
Medications. Given that medications and behavioural treatments might synergistically 
moderate each other (Aman et al., 2009) or behavioural intervention effects and medication effects 
might be additive in a straightforward manner (Scahill et al., 2012), medications were included in 
the analysis. Medication information was obtained through review of individual case information 
and was included as one of the variables in factor analysis. In present sample, medications taken 
include selective serotonin reuptake inhibitors (e.g., Fluoxetine), selective norepinephine reuptake 
inhibitor (e.g., Atomoxetine), hormones (e.g,, melatonin), antipsychotics (e.g., Risperidone), central 
nervous system stimulant (e.g., Concerta) and antihistamines (e.g., Trimeprazine, Phenergan, 
Vallergan). No children taking anti-epilepsy medications or asthma medications was included in the 
present study. The use of medication was categorised and scored as follows:  0 = no medication, 1 = 
melatonin, 2 = use of psychotropics, and 3 = use of both melatonin and psychotropic medications. 
In the present study, the category of medications was included as one of the measures used to 
identify latent variables that would serve as a dimension of child clinical complexity. 
Latent variables of child clinical complexity.  
In the present study, following Kazdin and Whitley (2006), data from baseline measures of 
children’s daytime functioning and behaviour (i.e., CBCL, GARS-2, and VABS II), measures of 
children’s sleep problem (i.e., CSHQ), categorical variable of comorbidity and categorical variable 
of medications were used to identify latent variables that would serve as dimensions of clinical 
complexity.   
Data Analysis  
 Existing clinical data from 31/42 participants in the Sleep and Autism study was analysed. 
Age, gender, comorbidity, prescribed medications, v-Scale scores of the receptive and expressive 
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communication sub-domains of the VABS II, T-scores of the CBCL, raw scores of CSHQ, severity 
level scores of GARS-2, and scores of SPS were entered into an Excel spreadsheet. Four data 
analysis steps were employed in present study. These steps were (1) descriptive and exploratory 
analysis, including bivariate correlations; (2) treatment outcome analysis; (3) factor analysis relating 
to child complexity; and (4) multiple regression to examine the relationship of any complexity 
factors to treatment outcome. All statistical calculations were performed using the Statistical 
Package for the Social Sciences software, SPSS Version 25 (IBM Corporation, Released 2017).    
Descriptive and exploratory analysis.  
The descriptive statistics were calculated for the research sample. This included means, 
standard deviations, the range and the shape of the frequency distributions, as measured by 
skewness and kurtosis, and clinical cutoff values for any measures where available. Descriptive 
statistics are useful for investigating characteristics of data and examining the validity of statistical 
assumptions underlying inferential multivariate statistical test (Meyers, Gamst, & Guarino, 2006). 
In descriptive statistics, measures of skewness and kurtosis can be used to analyse the normative 
distribution of data and to examine minimum, maximum, and mean values (Grant, Ries, & 
Thompson, 2016).  
In the present study, means and standard deviations were calculated for all the variables 
based on data recorded in sleep diaries. Specific descriptive statistics were chosen to screen data 
and to assess the normality of data distribution using both quantitative measures of skewness and 
kurtosis and graphical presentation. Skewness is a measure of the asymmetry in a data distribution 
and is quantified by the extent to which a data distribution differs from a normal distribution. 
Kurtosis is a measure of the height of the peak of a probability distribution. A standard normal 
distribution has kurtosis of 3. Any kurtosis bigger than 3 can be visualized as a thin bell-shaped 
distribution with a high peak and thin distribution tails. Kurtosis smaller than 3 corresponds to a 
broad bell-shaped distribution with a low peak and thick distribution tails. Both skewness and 
kurtosis may serve as indicators of normality (Kallner, 2018). For a normally distributed variable, 
Page 77 of 167  
the skewness values and kurtosis values will be close to zero (Meyers et al., 2006). A rule of thumb 
to test whether the departure from normality is not too extreme is to divide the skewness and 
kurtosis values by the corresponding standard error and the results should not be greater than ± 1.96 
(Rose, Spinks, & Canhoto, 2015).  
Pearsons Correlations. Pearson correlations were computed to determine the relationship 
between pre-treatment scores for all complexity and comorbidity measures used in the study. 
Pearson correlation is commonly used to determine how closely two variables are related. 
Correlation coefficients (r) can vary from -1 to 1. A positive r denotes that an increase in the value 
of one variable would lead to an increase in the other variable. Correlation coefficients as high as 1 
or -1 are very rare (Emerson, 2015). Any r value between .70 and .90 are considered high, those 
between .50 and .70 are considered moderate and those between .30 and .50 are considered low. 
Any r value between .00 and .30 are negligible (Mukaka, 2012).  
Treatment Outcomes Analysis.  
Statistical analysis was undertaken to determine whether treatment altered the child’s sleep 
to a clinically significant degree. The first step in the analysis was to provide descriptive statistics 
on the independent variables obtained pre- and post-treatment. Examples of these descriptive 
information are means, standard deviations, range, and distributions. Results from paired sample t 
tests was then used to determine whether the differences pre- and post-treatment were statistically 
significant. A commonly used effect size, Cohen’s d, was then calculated to quantify the 
improvements observed pre- and post-intervention. Effect size d is based on the difference between 
observations, divided by the average standard deviation of these observations (for within-sample 
data). An effect size of 0.2 is considered small, those between 0.2 and 0.5 are considered as 
medium, those between 0.5 and 0.8 as medium to large, and those > 0.8 are considered large 
(Cohen, 1988). Effect size estunates provide a more generally interpretable description of the size of 
observed effects that is independent of the possibly misleading influences of sample size (Fritz, 
Morris, & Richler, 2012).    
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Changes over time in SPS scores for each case were plotted as a modified Brinley plot 
(Blampied, 2017). Modified Brinley plots were used to identify systematic effects of treatments. On 
modified Brinley plots, all points directly on or clustered about the 45o diagonal line signal no 
treatment effect. Systematic movements of points above or below the diagonal line signal either 
improvement or deterioration for some or all participants. Modified Brinley plots complement other 
forms of analysis because of the ability to show direction and extent of change for each participant 
relative to both that individual’s pre-treatment state and that of other participants, thus permitting 
assessment of the consistency with which outcomes are replicated (Blampied, 2017) case by case.    
Factor Analysis.  
Child complexity is a latent variable and is not directly observable. Exploratory factor 
analysis was, therefore, used to detect any unobservable (latent) variables representing the 
complexity construct (Zygmont & Smith, 2014) and also used to summarize and combine the seven 
measures (number of medications, comorbidity, VABS receptive, VABS expressive, CBCL, GARS 
severity level, and CSHQ) into these underlying latent variables. In order to determine the 
factorability of an intercorrelation matrix, two tests were conducted; the Kaiser-Meyer-Olkin 
measure of sampling adequacy and Bartlett’s test of sphericity. The Kaiser-Meyer-Olkin measure of 
sampling adequacy indicates the proportion of variance in the variables that might be caused by 
underlying factors (“IBM Knowledge Center,” n.d.). Acceptable values for the Kaiser-Meyer-Olkin 
measure of sampling adequacy range from 0.5 to 1 (Hutcheson & Sofroniou, 1999). Any value less 
than 0.5 indicates that the results of the factor analysis probably won’t be very useful (“IBM 
Knowledge Centre,” n.d.). Bartlett’s test of sphericity indicates whether the correlation matrix is an 
identity matrix, in which all the diagonal elements are 1 and all off diagonal elements are 0 
(“UCLA: Statistical Consulting Group,” n.d.). A significance level of less than 0.05 indicates that a 
factor analysis may be useful with the data (“IBM Knowledge Centre,” n.d.). If both the value of 
Kaiser-Meyer-Olkin measure of sampling adequacy is less than 0.5 and the significance level of the 
Bartlett’s test of sphericity is much more than 0.5, then factor analysis would not be useful.  
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The factor analysis step used in the study involved a Principal Component Analysis 
extraction method using Varimax with Kaiser Normalization rotation method. Principal Component 
Analysis is a way of identifying trends and patterns in data with the goal to highlight similarities 
and differences (Smith, 2002). The criterion for terminating the number of factors being extracted in 
the analyses was an eigenvalue of 1.0 (Grant, Ries, & Thompson, 2016). The goal of Principal 
Component Analysis is to explain as much of the variance in the matrix of raw scores using as few 
components as possible. To allow for theoretical interpretation, varimax rotation is used to clarify 
the unrotated factor loading matrix (Zygmont & Smith, 2014). In Varimax rotation, the variance 
accounted for by each of the factors is maximized and the total amount of variance accounted for is 
redistributed over the three extracted factors (“UCLA: Statistical Consulting Group,” n.d.). Based 
on the results of factor analysis, the scores of the latent variables, commonly called factor scores, 
can be predicted. In present study, regression predictors (Thomson, 1934; Thurstone, 1935, as cited 
in Devlieger, Mayer, & Rosseel, 2015) are used to compute the factor scores to be used in the 
subsequent linear regression.  Note that if child complexity is a single, real construct, the 
expectation is that there would be a single factor extracted by the factor analysis.  
Multiple Regression.  
As the final step of data analysis, child’s age, gender, and the one of more factor scores 
obtained from the factor analysis were used as predictors of treatment responses. A hierarchical 
multiple regression is performed in order to control for the effects of covariates and to test the 
effects of certain predictors independent of the influence of others. In the hierarchical multiple 
regression, sociodemographic variables (e.g., age and gender) were entered into the first block, and 










 This chapter presents the descriptive statistics of pre-treatment scores on the VABS 
receptive and expressive subscale, CBCL, CSHQ and SPS and post-treatment SPS scores. A 
Pearson correlation matrix is presented to determine the associations among age, gender, and all 
pre-treatment and post-treatment scores. Modified Brinley plots are presented for pre- and post-
treatment SPS scores. Model summaries from multiple regression analyses are also presented.  
 Information on age, gender, medication, comorbidity, pre- and post-treatment SPS scores 
were available for the 31 children. For 24 out of 31 children, parents or caregivers completed the 
GARS, VABS receptive and expressive subscale, CBCL, and CSHQ. Two children were siblings 
and had the same parents.   
Quality of Data   
 The parents or caregivers of 3 children did not complete VABS Receptive and Expressive 
scores. The CBCL was not administered to 6 out of 31 children. The GARS was not administered to 
7 out of 31 children. Pre-treatment CSHQ scores were not available for 5 out of 31 children. Out of 
these 5 children, the CSHQ could not be administered to one of the children because the child’s age 
was outside of the validated range for the CSHQ. Lastly, three children were administered the 
CSHQ abbreviated version.  
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Child VABS Receptive and Expressive, CSHQ, CBCL Measures     
Table 2 
Descriptive Statistics for Children Pre-treatment Measures 
Measures  N M SD Range Min Max  Skewness   Kurtosis  Skewness Kurtosis 
         Statistics  Std. Error Statistics  Std. Error Statistics Statistics 
                           Std. Error       Std. Error 
VABS Receptive 28 8.61 2.17 8.0 5.0 13.0 0.31  0.44  -0.40  0.86  0.70  -0.47 
VABS Expressive 28 9.29 2.68 11.0 5.0 16.0 0.58  0.44  0.64  0.86  1.32  0.74 
CBCL total  25 68.48 11.0 49.0 43.0 92.0 -0.41  0.46  0.73  0.90  -0.89  0.81  
CSHQ   26 51.54 8.50 33.0 36.0 69.0 -0.06  0.46  -0.35  0.89  -0.13  -0.39 
Note. N = Participants, M = Mean, SD = Standard Deviation, Min = Minimum, Max = Maximum 
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The Relationship between the VABS Receptive, VABS Expressive, CBCL, and CSHQ 
Table 3 
Pearson Product Moment Correlation of pre-intervention psychometric scores 
Variable    1  2  3  4  5  6  7 
1. Medication    1  0.29  -0.382* -0.21  0.07  0.11  -0.03 
2. Comorbidity     1  -0.18  0.23  0.34  -0.35  0.12 
3. VABS Receptive       1  0.563** 0.06  -0.02  -0.17 
4. VABS Expressive         1  0.35  -0.28  -0.05    
5. CBCL Total           1  -0.18  0.26 
6. GARS Level             1  0.09 
7. CSHQ                1 
Note. Correlations printed in bold are significant; *p < .05., **p < .01. 
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Child SPS Measures     
Table 4 
Descriptive Statistics for Children SPS Pre- and Post-treatment Scores 
Measures  N M SD Range Min Max  Skewness   Kurtosis  Skewness Kurtosis 
         Statistics  Std. Error Statistics  Std. Error Statistics Statistics 
                 Std. Error      Std. Error 
Baseline  31 5.61 2.69 11.0 1.0 12.0 0.42  0.42  -0.09  0.82  1.00  -0.11  
Post-treatment  31 2.26 1.61 6.00 0.00 6.00 0.57  0.42  -0.26  0.82  1.36  -0.32 
Short-term FU  23 2.17 1.90 7.00 0.00 7.00 0.73  0.48  0.11  0.94  1.52  0.12 
Long-term FU  22 1.77 1.69 6.00 0.00 6.00 0.98  0.49  0.58  0.95  2.00  0.61 
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Descriptive and Exploratory Analysis 
Table 2 displays the means, standard deviations, range, minimum and maximum values, 
skewness and kurtosis statistics for VABS receptive and expressive language, CBCL total 
behaviour, and CSHQ.  
  Prior to treatment, the average v-Scale score on the VABS Receptive subdomain (8.61) and 
VABS Expressive subdomain (9.29) were considered low (Sparrow, Cicchetti, Saulnier, 2016). 
Average CBCL total behaviour problem score (68.48) was in the borderline clinical range. The 
average score on the CSHQ (51.54) was within the clinical range. The results of dividing skewness 
and kurtosis value by its corresponding standard error were also shown on Table 2. The results were 
all well within ± 1.96 limits, suggesting that the departure from normality is not too extreme.  
 Pearson product-moment correlation coefficients were computed to determine the 
association between pre-treatment scores used in the study. These correlations are presented in 
Table 3. Statistically significant correlations are observed between three variables. These 
correlations were large enough to reject the null hypothesis that the true value of r in the population 
= 0.  Medication had a low negative correlation with VABS Receptive scores. As expected, VABS 
Receptive had a moderate positive correlation with VABS Expressive scores.  
 A weak but significant negative correlation was found between medication and VABS 
Receptive scores indicating increased use of melatonin and/or psychotropic medications was 
correlated with lower VABS Receptive score. This correlation was in the direction expected 
because while the use of psychotropic medications might not be effective for the core features of 
ASD (social and communication impairment) (Madden et al., 2017), the use of melatonin alone 
seemed to improve communication (Wright et al., 2011). Hence, the positive impact of melatonin 
on communication might be diluted by the lack of impact of psychotropics on communication since 
the present study combined both psychotropics and melatonin into the categorical variable of 
medication.   
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 A significant strong positive correlation was found between VABS Receptive and VABS 
Expressive scores indicating difficulty in receptive communication domain was correlated with 
difficulty in expressive communication domain. This correlation was in the direction expected 
because individual challenges in using word and sentences to gather and provide information would 
be associated with challenges to listen, to pay attention and to understand.    
 No significant correlations were found between medication and comorbidity, VABS 
Expressive, CBCL, GARS level, or CSHQ. No significant correlations were found between 
comorbidity and VABS Receptive, VABS Expressive, CBCL, GARS or CSHQ. No significant 
correlations were found between VABS Receptive and CBCL, GARS or CSHQ. No significant 
correlations were found between VABS Expressive and CBCL, GARS, or CSHQ. No significant 
correlations were found between CBCL and GARS or CSHQ and lastly, no significant correlations 
were found between GARS and CSHQ.  
Treatment Outcomes Analysis 
Table 4 displays the means, standard deviations, range, minimum and maximum values, 
skewness, and kurtosis on the SPS scores at baseline, post-treatment, short-term follow-up and 
long-term follow-up. SPS scores obtained at baseline, post-treatment and short-term follow-up are 
normally distributed, as shown by the results of dividing skewness and kurtosis value by their 
corresponding standard error. Almost all results were well within ± 1.96 limits, suggesting that the 
departure from normality is not too extreme; however, the results for long-term follow-up SPS 
scores exceeded the 1.96 limits and seemed to suggest some departure from normality.  
Results from paired samples t tests indicated that SPS scores were statistically significantly 
lower post-treatment (M = 2.26, SD = 1.61) than pre-treatment (M = 5.61, SD = 2.69), t(30) = 6.64, 
p < .001, d = 1.51. The effect size was considered large and reliably different from zero (95% CI 
[2.32, 4.39]).  This was also the case at  short-term follow-up (M = 2.17, SD = 1.90) (M = 5.43, SD 
= 3.01), t(22) = 5.08, p < .001, d = 1.30  (95% CI [1.93, 4.59]) and  at long-term follow-up (M = 
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1.77, SD = 1.69) than pre-treatment (M = 5.68, SD = 3.08), t(21) = 5.69, p < .001, d = 1.57  (95% CI 
[2.48, 5.34]).  At each time point the effect size was large and reliably different from zero. 
Modified Brinley Plots Interpretation 
As seen in Figure 1, modified Brinley plots show individual changes pre- and post-
intervention simultaneously on one graph enabling the identification of systematic effects of an 
intervention. X-axis represents pre-intervention scores and Y-axis represents post-intervention 
scores. Each point on the graph represents an individual’s data with the X coordinate being the pre-
intervention score and Y coordinate being the post-intervention score. A vertical line represents the 
clinical cut-off for pre-intervention scores and a horizontal line represents the clinical cut-off for 
post-intervention scores. Together with the 450 diagonal line (i.e., line of no change), the horizontal 
and vertical clinical cut-off lines partition the graph into five zones. Starting from the lower left-
hand corner and moving anti-clockwise, these zones are “Pre: Non-clinical, Post: Non-clinical”, 
“Pre: Clinical, Post: Non-clinical”, “Pre: Clinical, Post: Clinical but improved”, “Pre: Clinical, Post: 
Clinical but worsened”, and “Pre: Non-clinical, Post: Clinical”. For those individuals that fall within 
the first zone “Pre: Non-clinical, Post: Non-clinical”, the interpretation is that the individual’s pre-
and post-intervention scores both fall below the clinical cut-off line. For those individuals that fall 
within the second zone “Pre: Clinical, Post: Non-clinical”, the interpretation is that improvement 
has been achieved since the score, above the clinical cut-off line before treatment, has dropped 
below the clinical cut-off after treatment. Finally, for those individuals that fall within the last zone 
“Pre: Non-clinical, Post: Clinical”, the interpretation is that deterioration has occurred since the 
score, below the clinical cut-off before treatment, has surpassed the clinical cut-off post treatment.        
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Figure 1. Conventions for interpreting modified Brinley plots where reduction in score represents 
clinical improvement (Blampied, 2017).  
 
Modified Brinley Plots – SPS scores 
 The SPS scores are presented below on modified Brinley plots showing individual change 
from pre- to post-intervention, short-term and long-term follow-up. Given that SPS scores are 
formulated so that a comparable measure is available to show change, the determination of any 
clinical cut-off point is beyond the scope of this thesis. Nevertheless, Figure 2 and 3 clearly shows 
that the baseline SPS scores were much higher than post-treatment, short-term, and long-term 
follow-up SPS scores. As seen in Figure 2 (A), twenty seven out of 31 children show improvement. 
The remaining 4 children either did not show any improvement since their data points lie on or near 
the 45-degree diagonal lines of no change (i.e. no or minor systematic differences between pre- and 
post-intervention/STFU SPS scores). Similarly, as seen in Figure 2 (B), nineteen out of 23 children 
show improvement. The remaining 4 children either did not show any improvement since their data 
points lie on or near the 45-degree diagonal lines of no change.  
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 Finally, similar trends are observed in Figure 3. Nineteen out of 22 children show 
improvement. The remaining 3 children did not show any improvement since their data points lie 
near the line of no change. 
Factor Analysis 
 A factor analysis of the child complexity and comorbidity data was performed using the 
Principal Component Analysis method of factor extraction. Principal Component Analysis arranges 
the variables into separate factors based on the strength of correlations. To determine whether 
correlations support factor analysis, the Kaiser-Meyer-Olkin measure of sampling adequacy is 
calculated. The Kaiser-Meyer-Olkin measure of sampling adequacy indicated that the strength of 
the relationships among variables was acceptable (KMO = 0.50). Bartlett’s test of sphericity 
indicated that the correlations within the correlation matrix was not significant (χ2 (21) = 29.7, ns). 
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Figure 2. Modified Brinley plot showing change on SPS scores from pre- to post-intervention (A) 
and short-term follow-up (B).  
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Figure 3. Modified Brinley plot showing change on SPS scores from pre-intervention to long-term 
follow-up. 
 
However, since results from one of the two test was adequate, it was acceptable to proceed with the 
analysis.    
 Three factors with eigenvalues greater than one were extracted. A Varimax rotation with 
Kaiser Normalization was performed. The obtained rotated component matrix is displayed in Table 
5. After Varimax rotation, the first factor was robust, with an eigenvalue of 2.02 and accounted for 
28.8% of the variance in the data. The second factor had an eigenvalue of 1.59 and accounted for an 
additional 22.7% of the variance in the data. The third factor had an eigenvalue of 1.40 and 
accounted for an additional 20.0% of the variance in the data. Cumulatively, the three factors 
accounted for a total of 71.5% of the variance in the data. Factor analysis of the child complexity 
and comorbidity items used in the present study revealed three factors were sufficient to explain the 
underlying latent variables. 
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Table 5 
Rotated Component Matrix for child complexity factors 
Measures      Factor I Factor II Factor III 
Medication      -0.71  0.29  -0.04 
Comorbidity      -0.31  0.72  0.30 
VABS Receptive     0.86  -0.04  -0.23 
VABS Expressive     0.79  0.40  0.13 
GARS Level      -0.10  -0.79  0.12 
CSHQ       -0.17  -0.18  0.88 
CBCL       0.16  0.40  0.67 
Bold-face values indicate the factor that the variables was adopted onto.   
The factors were named as follows: I. Medication-Communication (Medication, VABS 
Receptive and VABS Expressive), II. Psychopathology Severity (Comorbidity and GARS level), 
III. Behaviour and Sleep Problems (CSHQ and CBCL). Overall, the factor analysis revealed that all 
items loaded onto these three factors.  
Multiple Regression  
 Table 6 presents the results from hierarchical multiple regression analyses using the 
treatment outcome scores as predicted variables. Age and gender were entered at Step 1. At Step 2, 
the role of Factor Score 1, 2, and 3 were examined controlling for age and gender. Factor scores 
were produced using regression approach and were assigned to each child for each of the 3 
complexity factors. These factor scores were treated as variables in the hierarchical multiple 
regression. The hierarchical multiple regression revealed that, at Step 1, Age and Gender 
contributed significantly to the regression model, F(1,20) = 3.64, p<.05) and accounted for 29% of 
the variation in SPS score changes. Introducing the Factor Score variables explained an additional 
21% of variation in SPS score changes and this change in R2 was significant, F(1,20) = 3.00, 
p<.05). When all five independent variables were included in step 2 of the regression model, only 
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Factor Score 3 was the significant predictor of changes in SPS scores. Together the five 
independent variables accounted for 50.0% of the variance in SPS score changes.      
Table 6 
Summary of Hierarchical Regression Analysis for Variables predicting changes in SPS score  
Variable     β t R R2 ΔR2 Increment (%)a 
Step 1        0.54 0.29 0.29  29 
 Age      0.32 1.53   
Gender    0.35 1.67 
Step 2        0.71 0.50 0.21  21  
 Age      0.07 0.30 
 Gender    0.35 1.71 
Factor Score 1    -0.11 -0.57 
Factor Score 2    0.23 1.10 
 Factor Score 3    0.46 2.26*      
Note. N = 21; *p < .05 
a Represents proportion of variance accounted for by variables at their entry point into regression 
equation. R2/ΔR2 values multiplied by 100. 
 
An additional analysis was conducted on both CSHQ and CBCL scores – components of 
Factor Score 3. Using the median of CBCL T-scores, the group was split into two – a Low CBCL 
group and a High CBCL group. Means and standard deviations of the SPS change scores between 
the two groups were used to calculate the Cohen’s d effect size. A medium to large Cohen’s d effect 
size was obtained (d = 0.62) when evaluating the differences in mean SPS change scores between 
the low CBCL and high CBCL group. Similarly, using the median of CSHQ raw scores, the group 
was split into two – a Low CSHQ group and a High CSHQ group. Means and standard deviations 
of the SPS change scores between the two groups were also used to calculate the Cohen’s d effect 
size. A small to medium Cohen’s d effect size was obtained (d = 0.38) when evaluating the 
differences in mean SPS change scores between the low CSHQ and high CSHQ group. Also, 
Page 93 of 167  
looking at the standard deviations of the two groups based on either CBCL median split or CSHQ 
median split, higher CBCL T-scores or CSHQ raw scores are associated with reduced variation in 
changes in SPS scores. In other words, a comparison of the groups on the change of SPS scores 
indicated that children with more behaviour or sleep problems showed less change in the SPS 
scores. Nevertheless, children with more sleep problems still responded reasonably well as 
measured by the change in SPS scores and the effect size and changes for these children were 
medium to large. For children with more behaviour problems, there were responses to treatment, 
however, the effect size and changes for these children were small to medium. 
  





 The present study had three research aims: (1) to investigate whether a multi-component, 
parent-implemented, FBA informed treatment would result in a reduction in sleep problems; (2) to 
investigate the existence of latent complexity variables that may affect children’s responses to 
treatment; and (3) to investigate whether the latent complexity variables and child characteristics 
(i.e., gender, age, autism core symptoms severity, co-morbid psychopathology, sleep problems 
severity, behaviour severity, communications and medications) serve as predictors of treatment 
response.  
 In the present study, the implementation of a multi-component, parent-implemented, FBA 
informed treatment resulted in a reduction in sleep problem severity, as calculated using the SPS 
scoring system. In addition, out of the seven dimensions of child complexity that were analysed 
(Medication use, presence of comorbidities, VABS Receptive and Expressive language scores, 
GARS symptom severity level, CSHQ and CBCL scores), three latent complexity variables were 
identified. These latent complexity variables were named Medication-Communication (as measured 
by the types of medication and the VABS communication sub-domain), Psychopathology Severity 
(as measured by comorbidity categories and the GARS severity level), and Behaviour and Sleep 
Problems (as measured by CSHQ and CBCL). Only one of the latent complexity variables  
underlying sleep and behaviour problems served as predictors of treatment response, as measured 
by changes in SPS score. These findings will be discussed in detail in the following sections.  An 
overview of the strengths and limitations, clinical implications and recommendations for future 
research will also be provided.   
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Reductions in sleep problems following multi-component, parent-implemented, FBA-
informed treatment  
Following treatment, a significant reduction in SPS scores was observed for 26 out of the 31 
participants. This change was also reflected in a reduction in CSHQ scores for 19 out of the 22 
participants who also had post-treatment CSHQ scores. Prior to the intervention, 24 children (77%) 
met the CSHQ criteria for the presence of a sleep disorder. When assessed with CSHQ following 
intervention, 10 of the 24 children no longer met this criterion, and another seven of the children 
had a reduction in their CSHQ score. In other words, improvements were observed in 71% of those 
children who originally met the CSHQ criteria of sleep disorder. These findings suggest that a 
multi-component, FBA-informed, parent-implemented intervention is effective in reducing sleep 
problems in children with ASD.  
The results of this study add to the existing literature by providing further support for the use 
of individualized FBA informed interventions to treat a range of common sleep problems in 
children with ASD (Jin et al., 2013; McLay et al., 2017; 2019). Whilst there is a large body of 
evidence to support the use of behaviourally-based treatments for sleep problems in children with 
ASD (Cuomo et al., 2017; Mindell et al., 2006; Turner & Johnson, 2012; Vriend et al., 2011), this is 
one of few studies to have used FBA to inform the formulation of  treatment plans (Jin et al., 2013; 
McLay et al., 2017; 2019). Treatment plans formulated based on the outcomes of FBA are likely to 
be more effective than treatments that are not informed by the behavioural function, because the 
treatment plans will address the individual-specific variables that precipitate and maintain the sleep 
problem (McLay et al., 2017).  
Another important finding of this study is that treatment gains were maintained at both 
short- and long-term follow-up for the majority of participants. The stability of treatment effects 
was assessed both 4-6 weeks (i.e. short-term) and 10-12 weeks (i.e. long-term) post treatment and it 
was found that treatment outcomes were further enhanced or maintained at short-term follow-up for 
18 out of 23 children and at long-term follow-up for 18 out of 22 children who provided data for 
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SPS score calculation. This is one of few studies that has examined both short- and long-term 
maintenance of treatment effects.  The majority of existing research on parent-implemented 
behavioural sleep interventions includes a much shorter follow-up period of 2 to 8 weeks (e.g., 
Austin, Gordon, & O’Connell, 2013; Christodulu & Durand, 2004; Fawkes, Malow, Weiss, 
Reynolds, & Loh, 2015; Knight & Johnson, 2014; Loring, Johnston, Shui, & Malow, 2018; Moss, 
Gordon, & O’Connell, 2014; Scantlebury, et al., 2018) or no follow-up information (e.g., Cortesi, 
Giannotti, Sebastiani, Panunzi,  & Valente, 2012; Delemere & Dounavi, 2018; Durand & 
Christodulu, 2004; Johnson et al., 2013; Malow et al., 2014; Reed et al., 2009; Schoen, Man, & 
Spiro, 2017). Long term maintenance of treatment effects is crucial for identification of effective 
interventions (Kirkpatrick, Louw, & Leader, 2019).  
Latent complexity variables that may affect children’s responses to treatment 
In order to detect any unobservable (latent) variables that may underpin the construct of 
complexity, an exploratory factor analysis of the presence of such latent variables underlying 
comorbidities, medication use, sleep problem severity (CSHQ), and measures of children’s daytime 
functioning and behaviour (i.e., CBCL scores, GARS symptom severity level, VABS Receptive and 
Expressive language scores) was conducted. This analysis yielded three factors relating to three 
dimensions of clinical complexity: a medication-communication domain, psychopathology severity 
domain, and behaviour and sleep problem severity domain. The medication-communication 
complexity domain was negatively correlated with medication and positively correlated with 
communication suggesting that the present sample was less complex in terms of medication, and 
more complex in terms of communication. Closer examination of the samples in the present study 
revealed that 20 out of 31 children in the present study did not take medications. Hence, the 
majority of the sample were at the least complex end of the medication-communication complexity 
continuum. In contrast, 26 out of 28 children had moderately low or low levels of expressive and 
receptive communication skills and thus, were on the complex end of the medication-
communication complexity continuum. The psychopathology severity domain factor was negatively 
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correlated with GARS level and positively correlated with comorbidity suggesting that the present 
sample was less complex in terms of comorbidity, and more complex in terms of GARS severity 
level. An examination of the data revealed that only 25% of the children had comorbid 
psychopathology. Thus, in terms of comorbidity, the sample was on the least complex end of the 
psychopathology severity continuum. In contrast, 75% of the children had a GARS severity level of 
2 or 3. Therefore, in terms of GARS severity level, the sample was on the complex end of the 
psychopathology severity continuum. Behaviour and sleep problems severity was positively 
correlated with both daytime behaviours, as measured on the CBCL, and sleep problems, as 
measured on the CSHQ suggesting that the present sample was complex both in terms of behaviour 
and sleep problems. Closer observations of the sample revealed that 75% of the children had CSHQ 
sleep problem severity scores that were in the clinical range and 61% of the children had a 
borderline or clinical CBCL scores. Thus, all the children were on the complex end of the 
behavioural and sleep problems complexity continuum. These results simply showed limited 
variability across all the measures taken from present sample.    
Predictors of treatment response 
In order to test the independent effects of a single predictor variable on treatment outcomes, 
independent of the influence of other predictors, a regression analysis was performed. Regression 
models that adjusted for age and sex suggested that change in severity of sleep problems was 
associated with severity of daytime behaviour and CSHQ scores. A clinical complexity dimension 
which was comprised of behaviour problems (as measured by CBCL) and sleep problems (as 
measured by CSHQ) emerged as a significant predictor of change in SPS scores pre- and post-
treatment. The results of the present study are consistent with the findings reported by Remington et 
al. (2007) in one of the most rigorously controlled 2-year longitudinal field study confirming the 
effectiveness of intensive behavioural intervention for children with ASD. Children with ASD who 
respond better have a greater severity of behaviour problems at baseline (Remington et al., 2007). 
Furthermore, the results of this study are also consistent with previous findings which suggest that 
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higher rates of challenging daytime behaviour is associated with higher rates of sleep problems 
(Allik et al., 2006; Cohen et al., 2014; Goldman et al., 2009; 2011; Malow et al., 2006; Mayes & 
Calhoun, 2009; Mazurek et al., 2019; Schreck et al., 2004; Tudor et al., 2012; Verhoeff et al., 
2018).   
Further analysis on the latent variables underlying CBCL and CSHQ scores was conducted 
by performing a median split to identify both the children who experienced a higher versus lower 
CBCL and CSHQ scores. A comparison of the groups on the change of SPS scores indicated that 
children with more behaviour or sleep problems showed fewer changes in SPS scores and changes 
in SPS scores were more prevalent for children with more sleep problems than for children with 
more behaviour problems.  
The remaining complexity dimensions of age, gender, medication-communication and 
severity of psychopathology were not significant predictors of changes in SPS scores. The results 
from the present study showed that age, gender, and latent psychopathology complexity factors 
comprised of both comorbidity and GARS level were weakly but positively linked with overall 
improvement however, this relationship was not significant. The latent medication-communication 
complexity factors comprised of medication and VABS communication was also weakly and 
negatively linked with overall improvement and the relationship was not significant.  
There is some evidence within general behaviour analytic research which suggests that 
children under 4 years of age respond more positively to behavioural interventions than older 
children (Flanagan et al., 2012; Perry et al., 2011). Hence, given that the present study had a 
relatively small sample size (n = 31) and 25 children (81%) were older than 4 years old, clear 
association between age at baseline and changes in sleep severity might not be able to be detected.  
The finding that gender was not a significant predictor of changes in SPS scores is 
unsurprising and is consistent with previous findings which suggest that, with the exception of a 
single study (Tiura et al., 2017) gender is not predictive of treatment outcome (Anderson et al., 
2007; Baker-Ericzen, Stahmer, & Burns, 2007; Flanagan et al., 2012; Kasari et al., 2012; Virues-
Page 99 of 167  
Ortega, Rodriguez, & Yu, 2013). The results of the present study are likely to be affected by the 
small sample of female participants (n = 6) since the limited sample of female participants may not 
be adequate in terms of statistical power to detect any association, a limitation cited also by Tiura et 
al. (2017). Nevertheless, while few studies have investigated the relationship between gender and 
treatment outcomes, this is an important area of research as it has implications for the 
individualization of treatment in children with ASD (Halladay et al., 2015).  
The number of medications being taken by study participants was not found to be a 
significant predictor of changes in SPS scores. This is somewhat surprising given that previous 
studies reported the positive effects of melatonin in combination with cognitive behavioural therapy 
in addressing sleep problems in children with ASD (Cortesi et al., 2012; Howes et al., 2018). 
Nevertheless, past studies also reported various side effects of prescribed medications in children 
with ASD (Hafterkamp et al., 2012; Marcus et al., 2009; McCracken et al., 2002; Posey et al., 2007; 
Simonoff et al., 2013; Wichniak et al., 2017). Antidepressants with activating properties (e.g., 
fluoxetine), psychostimulant medications (e.g., atomoxetine) and antipsychotics (e.g., risperidone) 
may all have a negative effect on sleep (i.e., sleep disruptions, insomnia, early morning waking, 
sedation or drowsiness). The findings should be interpreted with caution because of the following 
issues. First, only four children were taking melatonin together with psychotropics. Melatonin or 
psychotropics only were taken by four and three other children, respectively. The small sample of 
children taking medications might not allow for adequate statistical power to detect any association. 
Second, a categorical variable was used to measure the number of medications and not the effect of 
the medications. The lowest possible category denoted no medication use and highest possible 
category denoted use of both psychotropics and melatonin. Hence, the potential synergetic or 
antagonistic effects of antidepressants, stimulant, and antipsychotic medications were all clustered 
into a single category. This may have prevented the detection of an association between effects of 
medications and treatment responses.   
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In the present study, receptive and expressive communication level was not a significant 
predictor of change in SPS scores. This is somewhat surprising given that previous research has 
found that IQ combined with language ability is one of the  strongest predictors of response to 
behavioural intervention, i.e., higher adaptive behaviour scores are associated  with greater 
improvement following behavioural intervention (Eaves & Ho, 2004; Eikeseth et al., 2007; 
Flanagan et al., 2012; 2015; Kim et al., 2016; Magiati, Charman, & Howlin, 2007; Magiati et al., 
2011; Perry et al., 2011; Remington et al., 2007; Sallows & Graupner, 2005). Also, past studies had 
reported both negative effects of sleep problems on adaptive behaviour and negative impact of low 
adaptive function on sleep problems (Cohen et al., 2017; Krakowiak et al., 2008; Taylor et al., 
2012). The current finding should be interpreted with caution as the majority of the children in the 
sample had a moderately low or low level of expressive and receptive communication. Only two 
children had an adequate expressive communication level and a further two children had an 
adequate receptive communication level. As a result, the sample might lack heterogeneity in terms 
of the range of expressive and receptive communication to allow for detection of any association 
between communication level and treatment responses. Furthermore, it is important to note that the 
present study only measured one out of five domains of adaptive behaviour. The VABS scores of 
the other four domains of adaptive behaviour (i.e., daily living skills, socialization, motor skills, and 
maladaptive behaviour) were not obtained because the VABS was primarily used to inform the 
development of developmentally appropriate materials (e.g., social stories) and to better understand 
the adaptive functioning level of each child. Use of the VABS measure was limited in order to 
minimise parental burden and was not originally intended to be used to assess any pre- and post-
treatment change in adaptive functioning. In retrospect, further domains of the VABS could be used 
to get an additional measure of adaptive behaviour and social skills.  
In the present study, autism severity was not a significant predictor of change in SPS scores. 
The severity of autism symptoms has rarely been examined as a potential predictor of treatment 
outcome (Matson & Smith, 2008), and not at all within the sleep context. Furthermore, a variety of 
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measures of autism severity have been used in previous studies that have included children with 
ASD, making comparison difficult (Howlin et al., 2009). Overall, the findings of previous research 
are mixed. The majority of past studies suggest that lower baseline autism scores are predictive of 
better treatment outcomes (Ben-Itzchak & Zachor, 2007; Eaves & Ho, 2004; Perry et al., 2011; 
Sallows & Graupner, 2005; Vivanti et al., 2013), however there are noted exceptions to this. For 
example, Mello et al. (2018) reported that children with more severe autism symptoms, as measured 
by CARS, did not improve as much following behavioural intervention. The authors suggested that 
children with more severe symptoms might require a more intensive intervention and/or 
intervention did not target the salient symptoms of ASD.  The results from present study need to be 
interpreted with caution for several reasons. First, the present study used the GARS-2 as the only 
measures of autism severity. In comparison to the ADOS-G and ADI-R, which are commonly used 
in research, there is some evidence to suggest that the GARS/GARS-2 may underestimate the 
likelihood of ASD and that convergence with gold-standard research diagnostic measures is quite 
poor. Thus, caution should be applied when utilizing GARS/GARS-2 for both research and clinical 
purposes (Mazefsky & Oswald, 2006; South et al., 2002; Volker et al., 2016). Second, the present 
study uses the categorical variable of GARS-2 Severity level as a measure of autism severity. As a 
consequence, all of the children in the sample had either a GARS severity level 2 or 3. By using 
categorical data and not continuous variable, some important information may have been lost and 
the statistical power may have been reduced. In addition, considerable variability captured in the 
continuous data may have been unnecessarily subsumed within each category (Altman & Royston, 
2006). As such, the statistical power to detect any relationship between autism severity level and 
changes in SPS scores was reduced. A better alternative to using the GARS severity level could be 
to use a continuous variable and established autism measures, such as ADOS-G and ADI-R, to 
measure autism severity level (Hill et al., 2001; Klinger & Renner, 2000; Tanguay, 2000; Volker et 
al., 2016). The continuous variable would allow for greater variability to be captured and offer the 
ability to capture a weak association.   
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Finally, comorbidity was not a significant predictor of changes in SPS scores. 
Unfortunately, very few past studies have investigated the direct effect of comorbidity on treatment 
responses. Kazdin and Whitley (2006) reported that clinical complexity factors underlying 
comorbidity were not a significant predictor of changes in disruptive behaviour as treatment 
responses. Similarly, van der Heijden et al. (2018) reported no association between sleep problems 
in children with ASD and comorbid anxiety and depression. Nonetheless, the findings from present 
study should be interpreted with caution as only eight out of 31 children had comorbid 
psychopathology. Of those eight children, only two children had comorbid anxiety disorder, three 
other children had ADHD. Hence, the present study might not have the power to investigate 
comorbidity and treatment responses.  
Strengths of the current study 
To our knowledge, this is one of the few studies that has used FBA to inform the 
development of sleep treatment in children with ASD (Jin et al., 2013; McLay et al., 2017, 2019; 
Singh & Zimmerman, 2015; Spruyt & Curfs, 2015). Given the various factors contributed to the 
development and maintenance of sleep problems, comprehensive FBA-informed assessments could 
identify behavioural, psychological and environmental factors unique to the individual and allow 
for treatment to be designed and implemented specifically targeting these factors. Such treatments 
would be more effective because the choice of intervention is driven by the variables precipitating 
and maintaining the behaviour and these variables were specifically addressed (McLay et al., 2017).  
The data used in the present study was systematically collected in a larger Sleep and Autism 
study which employed a multiple-baseline across participants design. As suggested by Blampied 
(2001), several strengths of such research design were as follows. First, multiple repeated 
observations were performed on the individual level across consecutive observational or 
experimental phases. Second, functional analyses were performed at the individual level taking into 
account the uniqueness and singularity of participants. Third, analysis of therapeutic change was 
conducted based on the time-series data collected from each participant. Finally, clinical 
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innovations could be rigorously investigated and replications performed on multiple-baseline across 
participants to establish effectiveness and to map out the domain of generalisation (Blampied, 
2001).  
The results also add to the limited body of literature documenting the process of using 
individualized FBA informed interventions to treat a range of common sleep problems in children 
with ASD. In addition, this is one of the few studies that assessed the stability of treatment effects at 
both 4-6 weeks (i.e. short-term) and 10-12 weeks (i.e. long-term) post treatment. Most other studies 
have a much shorter follow-up period or limited follow-up (Christodulu & Durand, 2004; Delemere 
& Dounavi, 2018; Johnson et al., 2013; Kirkpatrick et al., 2019; Malow et al., 2014; Reed et al., 
2009; Scantlebury, et al., 2018; Turner & Johnson, 2012) and long-term follow-up data would 
naturally be more convincing than post treatment data (Kazdin & Whitley, 2006).  
Instead of relying solely on sleep diaries provided by parents or caregivers, the use of 
videosomnography in the present study allowed for verification of the reliability of the sleep diaries 
and at the same time gathering IOA data which further enhanced the reliability of observations. 
Videosomnography was found to be especially valuable in the present study since it was well 
tolerated by children with ASD and the data could be collected at home providing important 
information that might go undetected or falsely detected as awake by actigraphy (e.g., the child was 
awake but stayed sedentary while watching tablets or laptops; large amount of motor activity during 
periods of active rapid eye movement sleep (Hodge, Parnell, Hoffmann, & Sweeney, 2012; Moore, 
Evans, Hanvey, & Johnson, 2017; Sitnick, Goodlin-Jones, & Anders, 2008). Furthermore, the use 
of videosomnography also fulfilled the call for future research to use objective measure such as 
videotaping to collect IOA data (Delemere & Dounavi, 2018).  
The involvement of parents as the primary agent in implementing treatments in the home 
environment is another strength of the present study contributing to the increasing body of literature 
that involves parental agency. The present results confirmed the effectiveness of the parent as an 
agent of change, consistent with past studies that utilized parents to implement treatment for sleep 
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disturbances (Austin et al., 2013; Malow et al., 2014; Meltzer & Mindell, 2014; Moon, Corkum, & 
Smith, 2010; Moss et al., 2014; Reed et al., 2009; Sanberg et al., 2018). Furthermore, the present 
study extends the practice of increasing parental agency and utilizing parent-derived sleep goals 
with increasing parental involvement using the Guided Participation Model (Sanders & Burke, 
2014) which allows the development of sleep goals and treatment procedures in consultation and 
collaboration with parents (McLay et al., 2017). The use of the Guided Participation Model in the 
present study also helps to address possible barriers to treatment. Kazdin & Whitley (2006) 
suggested that barriers to treatment emerged in the context of parent contact with the treatment 
service, clinician, and intervention. Concern with the therapeutic relationship could be one barrier to 
treatment. By employing the Guided Participation Model, parents or caregivers were encouraged to 
actively participate in the intervention and decision-making. At the same time, clinicians aimed to 
establish and maintain an effective collaborative relationship with parents or caregivers in 
identifying treatment goals, in ensuring that parent goals are realistic and linked to appropriate 
strategies, and in empowering parents or caregivers to persist with change. Furthermore, clinicians 
were reminded to be alert to any signs of resistance, to address such resistance directly by exploring 
parents’ perspectives, to take a non-judgmental stance that validated parents experience and to assist 
parents in exploring the advantages and disadvantages of making change (Sanders & Burke, 2014)  
Effective behavioural treatments for sleep problems in children with ASD that can be 
reliably implemented within the home environment are limited (Sanberg et al., 2018). The present 
study demonstrated the effectiveness of multi-component and FBA informed treatments as 
implemented by parents or caregivers in a home setting. Being able to implement treatments at 
home is important since children with ASD might be averse to novel environments and a familiar 
environment might enhance the treatment responses (Moon et al., 2010; Moore et al., 2017; Sanberg 
et al., 2018).  
Finally, a strength of the present study is that it addressed the concerns among clinicians 
regarding the generalizability of findings from controlled trials to clinical practice given the 
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possibility of differences between research samples and patients seen in clinics. Patients seen in 
clinics are more complex and diverse and no exclusion or inclusion can be applied whereas 
inclusion and exclusion criteria for study participants is a standard and required practice for high-
quality research protocols (Patino & Ferreira, 2018). As mentioned above, children in present study 
were all from the larger Sleep and Autism study which employed single-case research design. The 
advantage of single-case research design allows for investigation to address the complexity 
presented at the individual level. To that end, children in the present study were as complex as 
patients seen in clinical practice given that all the children had a formal diagnosis of ASD and were 
either self-referral or referral by paediatricians or ASD case manager who was providing services to 
improve children’s communication and behaviour to the families with children with ASD.  
Limitations of the current study 
The main limitation of this study is that only a single measure is used to capture each of the 
complexity variables (e.g., ASD symptom severity was measured using only the GARS; 
communication was measured using only the VABS communication sub-domain scores; and 
behaviour problems were measured using only the CBCL). Given that there were many aspects 
within each dimensions of complexity, using multiple measures would allow for a more 
comprehensive understanding of each child’s functioning in a particular area (e.g., Anderson et al., 
2009; Ben-Itzchak & Zachor, 2007; Sallows & Graupner, 2005; Kazdin & Whitley, 2006; Magiati 
et al., 2007; Perry et al., 2011; Remington et al., 2007). The second limitation of this study is the 
use of the SPS scoring system. The SPS scoring system, whilst derived from SBS and NSF 
Guidelines is not a validated measure. Hence, no psychometric testing had been conducted to assess 
the reliability (i.e., the ability to produce consistent results on sleep problem severity), validity (i.e., 
the ability to produce true results of sleep problem severity) and sensitivity (i.e., the probability of 
correctly identifying children with sleep problems) of the measure. Hence, further evaluation on the 
criterion validity (i.e., a degree of relationship between SPS score and CSHQ score) and construct 
validity (i.e., extent to which SPS assesses sleep problem severity and is associated with evidence 
Page 106 of 167  
from objective measures such as videosomnography or polysomnography that measure sleep 
problems) would be desirable. Furthermore, SPS scores were only calculated based on set time 
periods (e.g., the final seven days of baseline). As a result, it may not reflect the complete picture of 
sleep problem severity during a particular phase, in its entirety. The third limitation of this study 
was the lack of comparison group given that all participants responded to treatment. Further 
classification of the group into responders and non-responders for comparison purposes were not 
possible. Future between-group comparison would be possible to better identify the characteristics 
of responders versus non-responders (Yoder & Compton, 2004). In contrast to Kazdin and 
Whitley’s (2006) study which included socioeconomic disadvantage and parent and family 
functioning as two of the domains of case complexity, the present study did not investigate these 
factors. Kazdin and Whitley (2006) reported that both socioeconomic disadvantage and parent and 
family functioning were unrelated to treatment outcome. Nevertheless, given that there were many 
sources of complexity in relation to families, there was a need to investigate the family complexity 
factors. A separate and concurrent study on family complexity factors is underway using the same 
sample of children as the present study. It is also important to note that there was some missing data 
at baseline, short-term and long-term follow-up. However, due to the small sample size, no 
approach was taken to replace missing values. Hence, the present results should be preliminary and 
further replication would be needed. Finally, as cautioned by Vivanti et al. (2014), instead of actual 
predictors of outcomes, the factors proposed in the present study might only be the variables 
associated with change (i.e., mediators or moderators of treatment response) since not all the 
observed change can be attributed to treatment (Yoder & Compton, 2004). Given that there is no 
standard way to measure case complexity (Kazdin & Whitley, 2006), there is a possibility that 
failure to consider and to control factors other than treatment that might contribute to change and 
failure to include key dimensions of complexity would prevent the identification of correlates of 
changes that might truly predict the treatment responses (Kazdin & Whitley, 2006; Vivanti et al., 
2014). 
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Recommendations for future research 
On the basis of the aforementioned limitations, a number of recommendations have been 
made for future research. A key consideration is to use a greater variety of measures to capture 
complexity which would enable one to develop a more comprehensive understanding of the 
dimensions of complexity. For example, diagnostic instruments such as ADI-R, ADOS and CARS 
could be used to evaluate autism severity (e.g., Anderson et al., 2009; Ben-Itzchak & Zachor, 2007; 
Perry et al., 2011; Shui et al., 2018) and measures such as the Aberrant Behaviour Checklist (Kaat, 
Lecavalier, & Aman, 2014), Interview for Antisocial Behaviour (Kazdin & Esveldt-Dawson, 1986) 
and DBC could be used to measure challenging daytime behaviour (e.g., Kazdin & Whitley, 2006; 
Mazurek et al., 2019; Remington et al., 2007; Shui et al., 2018), and the Child Symptom Inventory 
– 4 (Sprafkin, Gadow, Salisbury, Schneider, & Loney, 2002) could be used to measure co-occurring 
psychiatric symptoms (e.g., Pellecchia et al., 2016).  
Future research should attempt to objectively measure children’s daytime behaviour. Using 
observational recordings to measure the frequency and duration of challenging daytime behaviour 
would be one example. Together with the use of sleep diaries to capture information about daytime 
naps or other information such as events at school, these combinations of objective and subjective 
measures would provide a better measure of children’s daytime behaviour problems. 
 Further replications of key findings should be conducted and further investigation into the 
relationship between daytime behaviour and response to treatment is important. A recent pilot study 
had reported improvements in daytime behaviour (i.e., inattention, hyperactivity/noncompliance, 
repetitive behaviours and internalizing behaviours) following a brief behavioural intervention for 
insomnia in adolescents with ASD (Loring et al., 2018).  
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Clinical implications 
 The present study demonstrated the effectiveness of parent-implemented, function-based 
interventions to treat sleep problems in children with autism. Given that the latent variable 
comprising behaviour and sleep problems was a significant predictor of responses to treatment, an 
objective measure of daytime behaviour such as video recording will need to be used together with 
the parent- or caregiver-report CBCL score to prevent any bias associated with subjective measures. 
In terms of treatment, additional components to address behavioural problems will need to be 
formulated and included in the behavioural treatment package so that both behaviour and sleep 
problems can be addressed appropriately. Finally, the importance of a collaborative process in 
which decision making was driven by the child’s parents or caregivers should not be underestimated 
to ensure success in the implementation and adherence to treatment plan.       
Conclusion 
As demonstrated in the present study, reduction in sleep problem severity could be achieved 
through the use of a multi-component, parent-implemented, FBA informed treatments. In addition, 
the present study suggested that the severity of sleep and behaviour problems was the strongest 
predictor of response to treatment.  Comorbidity, autism symptoms severity, medications and 
communications did not seem to predict response to treatment. Overall, the study added to the 
current literature in terms of identifying possible predictors of treatment outcomes and effectiveness 
of functions-based interventions to treat sleep problems in children with ASD. A multimodal 
measurement of improvements observed that include objective measures such as videosomnography 
and subjective measures in addition to a greater variety of measures to capture complexity 
dimensions were recommended for future research to further improve the validity and utility of the 
SPS score. Finally, even if the treatment seemed to be less effective with more complex cases (i.e. 
those with more behaviour or sleep problems), that would not mean the treatment was ineffective, 
as shown by the small to medium effect size when categorized using behaviour problems and 
medium to large effect size when categorized using sleep problems. The present study suggested 
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that both more complex and less complex cases could respond to treatment and case complexity was 
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Appendices 
Appendix A. Child Information Sheet 
 
 
An investigation into the efficacy of treatments for sleep disturbance in 
children with autism 
 
Children’s Information Sheet 
 
 
Hello. My name is XX and I am a XX student at the University of Canterbury. I am doing a 
project about how to help children to sleep better and I would like for you to help me with 
this. 
 
I am going to be talking to you and your parent/s about ways to help you to sleep better. 
This means that I might be Skyping you, coming to your house, or your parent/s will be 
coming to see me at the University. 
 
There will be a video camera in your bedroom sometimes. This will help me to understand 
what you do when you are awake and asleep. Only your parents and other people working 
on this project will be able to see this video. We may ask you to wear an actigraph. An 
actigraph is worn on your wrist like a watch and it tells us when you are asleep and when 
you are awake.   
 
If you do not want to be a part of this project, you can tell me or your parents and you 
won’t need to be a part of it anymore. 
 
If you have any questions you can ask me or your parents whenever you like. 
 
Now we need to decide if you would like to do this. If you do want to be a part of my 
project then you can say “yes”. If you do not want to be a part of this project then you can 
say “no” and no one will mind. 
 








This research has received ethical approval from the University of Canterbury Human Ethics Committee, Private 
Bag 4800, Christchurch; email human-ethics@canterbury.ac.nz 
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“An investigation into the efficacy of treatments for sleep disturbance in 
children with autism” 
 
Children’s Consent Form 
 
My name is ____________________________________. 
 
 XXX has told me about the work that she is going to be doing with me and my 
parent/s. 
 
 XXX told me that she is going to be working with me and my parent/s to help me to 
learn to sleep better. 
 
 
 While XXX does this she will be asking my parents about my sleep each night and 
there will be a video camera in my room on some nights that is recording my sleep. 
 
 I know that if at any time I want to stop being a part of this project then XXX will stop 
recording data and this will be destroyed.  
 
 If I want XX to stop video recording my sleep then the camera will be taken out of 
my room and that will be fine. If I want any video footage to be deleted, I can tell 
XXX or my parents. 
 
 I was told that my parents/caregiver may sign this form for me and I think that is OK. 
 
 I would like a summary of the results of this project. 
 
 






If this form is signed on behalf of your child please acknowledge, by signing this form, that 
your child was verbally informed of the investigation and what it will involve and that they 
were unable to provide verbal or written consent that they would like to be a part of this 
research. 
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An investigation into the effectiveness of treatments for sleep disturbance in 
children with autism or features of autism  
 
Information for Parents/Caregivers 
 
This research has been assessed and approved by the University of Canterbury Human Ethics 
Committee (HEC 2018/47).  
 
Dear Parent/ Caregiver,  
 
We are a group of researchers at the University of Canterbury. Dr Laurie McLay is a Senior 
Lecturer in the School of Health Sciences at the University of Canterbury. Laurie has many years 
experience in working with children and young people with developmental disabilities and their 
families. Associate Professor Karyn France has lectured here for many years, has conducted 
research into the treatment of paediatric sleep disturbance and is a registered clinical psychologist 
with considerable clinical experience in this area. Professor Neville Blampied has a similar history 
of teaching and research. A number of Masters and PhD students and Child and Family Intern 
psychologists or registered psychologist also work on this project.   
 
We would like you and your child with autism to consider participating in this research study. The 
primary purpose of this study is to investigate the effectiveness of treatments for sleep disturbance 
in children with autism. Treatment can include a range of strategies, including both non-traditional 
approaches (such as white noise) and behavioural interventions. These approaches have been 
designed to minimise stress as much as possible for the parents and children using them. We are 
also interested in parents’ and children’s experiences in using the treatments and any changes to 
their lives, or their child’s lives, which result.  
 
As a part of this study we would also like to investigate the experiences of parents in implementing 
treatments for sleep disturbance, those treatments that they consider to be most acceptable, and 
the impact of successful treatment of sleep problems on parent and child wellbeing and quality of 
life. In order to do this we will ask you to complete some questionnaires about you and your child’s 
well-being and behaviour at the commencement and conclusion of treatment. We will also ask your 
perspective on the treatment that was provided. We will do this either during visits to your home, 
Skype interviews, or in a clinic at the University of Canterbury. 
 
If you agree to allow your child to be a part of this study, we will meet with you, or Skype you, to 
discuss your child’s sleep behaviour and find out more about him/her and your family. This initial 
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meeting will last for approximately 1-1 ½ hours. We will then ask you to complete sleep diaries in 
which you will record further information about your child’s sleep patterns. Sleep diaries will be 
recorded each day throughout all phases of the study as this will allow us to monitor the 
effectiveness of the treatment approach. The sleep diaries will take you up to five minutes to 
complete each night. You will also be asked to complete commonly used questionnaires in order to 
obtain information about your child’s sleep behaviour and the effects of treatment. It will take 
approximately 15 minutes to complete each questionnaire. When we have established an 
understanding of your child’s sleep behaviour, we will work with you to develop sleep-related goals 
for your child. This will involve a second treatment planning session which will last 1-1 ½ hours.   
 
To help us gather further information about your child’s sleep patterns we will bring or send a video 
camera to your home for some nights over the course of the programme, which is capable of 
recording all night sleep. In addition we may ask you, if possible, to use an actigraph with your 
child. This watch-like device records the movements associated with sleep and can be worn on the 
wrist or ankle, or secured into a pocket on your child’s pyjamas. This may offer an alternative to 
video cameras when appropriate. These methods will allow us to measure sleep behaviour at 
times when an adult is not present. We will demonstrate and explain how to use each of these 
methods for gathering information.  
 
When information about your child’s sleep behaviour has been gathered, treatment will commence. 
You will be offered a choice of treatment options. which you will then implement with the support of 
the research team. If you are dissatisfied with the treatment approach or the degree of progress 
that is being made then you will be offered a choice of another treatment option. We will provide 
you with all of the necessary information about each treatment approach and we will maintain 
regular contact with you during treatment. It is anticipated that your involvement in the study will 
occur over the course of a few months, but will depend on the rate of your child’s progress as well 
as your satisfaction with the progress. 
 
For the purpose of this project, myself (insert name), a psychologist/intern 
psychologist/Masters/PhD student will be working closely with you to conduct the necessary 
assessments and formulate interventions. XX, a research assistant/Masters/PhD student who also 
works as a part of our sleep team, may look at some of the information that we collect, such as 
video recordings and actigraph data. 
 
Your child will be assigned a code name to ensure anonymity and anything that you or your child 
says or does will be kept confidential. The results of the study may be submitted for publication to 
national or international journals and may also be presented at conferences. No identification of the 
child or family will be possible from any report, publication or presentation.  
 
If you want to withdraw from the project before completion, you can do this at any time without penalty 
or repercussions.   
 
Should you require any additional information about the study or if you would like to access the study 
findings you are able to do so at any stage.  The data which is produced from the research will be 
kept in a locked cabinet at the University of Canterbury for a minimum of ten years. 
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If you agree for your child to take part in the research, please sign the consent form that is attached.   
 
If you have any complaints you may contact the Chair of the University of Canterbury Ethics 
Committee. The contact details are given below.  
 
If you have any questions about this project please feel free to contact Dr Laurie McLay: Phone (03) 
369-3522 or, email: laurie.mclay@canterbury.ac.nz 
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Appendix D. Parent Consent Form 
 
An investigation into the effectiveness of treatments for sleep disturbance in 
children with autism 
 
CONSENT FORM FOR PARENTS/ CAREGIVERS 
 
This research has been assessed and approved by the University of Canterbury, Human 
Ethics Committee (HEC 2018/47). 
 
 I wish to participate in the project, “An investigation into the efficacy of treatments 
for sleep disturbance in children with autism” 
 
 I have read and been given a full explanation of this project and have had the 
opportunity to ask questions.   
 
 I understand what will be required of myself and my child/the child in my care during 
this project. 
 
 I understand that the investigators do not foresee any potential risks to me or my 
child as a result of participating in this study. However, if the intervention results in 
an increase in family stress, the staff working with us will provide support.  
 
 I understand that all information about my family will be treated as confidential 
unless there is concern about anyone’s safety. In this case my clinician will need to 
speak to someone else to ensure the safety risk is removed. No findings that could 
identify me or my child will be published 
 
 I understand that the findings of this study may be published in a research journal or 
at a conference and that the anonymity of my child and I will be maintained 
 
 I understand that participation in this project is voluntary and that I can withdraw my 
child or he/she can withdraw from the project at any time without repercussions. I 
can also withdraw any data that has been collected at any time prior to the 
publication of that data 
 
 I understand that all research data that is collected will be securely stored at the 
University of Canterbury for a minimum of ten years 
 
 I understand that I am able to request a copy of the results of this research, should I 
wish to do so, and that these results will be provided for me 
 
Page 163 of 167  
 I allow video-taping of my child’s sleep behaviour to be completed by the researcher 
and understand that this videotape will be used for data gathering purposes only. I 
also understand that I have the right to request that video footage is destroyed at 
any stage. 
 






















 I would like a summary of the results of this project. 
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Appendix E. Sleep Diary Template 
Sleep Diary  
Child’s Name:                         
 










 Setting (where 
fell asleep)         
   
Time asleep          
   
Time awake 
        














fell asleep)         
   
Time put to bed 
     
   
Frequency of 
Curtain calls*     
   
Curtain calls 

































   
 
 
Best estimate of 
time asleep              
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_______ mins 
             
 
_______ mins 



















































    
 
                            



























            
 
_______ mins 
             
 
_______ mins 








































    
                            
  Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
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An Investigation into the Efficacy of Treatments for Sleep Disturbance in 
Children with Autism 
 
AUDIOVISUAL RECORDING CONSENT FORM 
 
 
You have been given this form because the researchers have asked your permission to 
take audiovisual recordings of your child’s sleep behavior.   
 
Please read the statements below, which explain the purpose of audiovisual recording 
and how your privacy will be protected: 
 
 The purpose of recording is to gather data for the research project 
 
 Audiovisual recording will only be done with your knowledge and consent 
 
 You can withdraw your consent to audiovisual recording at any time, without 
having to provide a reason for changing your mind 
 
 The audiovisual file will only be seen by the researchers 
 
 The audiovisual recording will be securely stored at the University of 




I hereby consent to audiovisual recordings being made on the above conditions. 
 
Signed: ______________________________ 
 
Date: ______________________________ 
